<?xml version="1.0" encoding="UTF-8"?>
<!-- generated by CLiX/Wiki2XML [MPI-Inf, MMCI@UdS] $LastChangedRevision: 92 $ on 16.04.2009 15:31:54[mciao0827] -->
<!DOCTYPE article SYSTEM "../article.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink">
<therapy  confidence="0.9511911446218017" wordnetid="100661091">
<header>
<title>Omega-3 fatty acid</title>
<id>22594</id>
<revision>
<id>244234917</id>
<timestamp>2008-10-09T22:12:23Z</timestamp>
<contributor>
<username>Stevenfruitsmaak</username>
<id>247845</id>
</contributor>
</revision>
<categories>
<category>Biologically based therapies</category>
<category>Lipids</category>
<category>Pages with DOIs broken since 2008</category>
<category>Fatty acids</category>
</categories>
</header>
<bdy>

For an explanation of <it>n</it> and numerical nomenclature (such as <it>n</it>−3 or 18:3), see <link xlink:type="simple" xlink:href="../975/10975.xml#xpointer(//*[./st=%22Nomenclature%22])">
Nomenclature of fatty acids</link>.<p>

<table class="infobox">
<header style="text-align: center; background: #eee;">
 Types of <link xlink:type="simple" xlink:href="../042/11042.xml">
fat</link>s in <link xlink:type="simple" xlink:href="../646/10646.xml">
food</link></header>
<row>
<col>
<list>
<entry level="1" type="bullet">

 <link xlink:type="simple" xlink:href="../748/264748.xml">
Unsaturated fat</link></entry>
<entry level="2" type="bullet">

 <link xlink:type="simple" xlink:href="../404/1051404.xml">
Monounsaturated fat</link></entry>
<entry level="2" type="bullet">

 <link xlink:type="simple" xlink:href="../513/1610513.xml">
Polyunsaturated fat</link></entry>
<entry level="2" type="bullet">

 <link xlink:type="simple" xlink:href="../487/263487.xml">
Trans fat</link></entry>
<entry level="2" type="bullet">

 Omega fatty acids:</entry>
<entry level="3" type="bullet">

 <link xlink:type="simple" xlink:href="../594/22594.xml">
ω−3</link></entry>
<entry level="3" type="bullet">

 <link xlink:type="simple" xlink:href="../218/681218.xml">
ω−6</link></entry>
<entry level="3" type="bullet">

 <link xlink:type="simple" xlink:href="../439/3110439.xml">
ω−9</link></entry>
<entry level="1" type="bullet">

 <link xlink:type="simple" xlink:href="../746/264746.xml">
Saturated fat</link></entry>
<entry level="2" type="bullet">

 <link xlink:type="simple" xlink:href="../034/9057034.xml">
Interesterified fat</link></entry>
</list>
</col>
</row>
<row>
<header style="text-align: center; background: #eee;">
See also</header>
</row>
<row>
<col>
<list>
<entry level="1" type="bullet">

 <link xlink:type="simple" xlink:href="../975/10975.xml">
Fatty acid</link></entry>
<entry level="1" type="bullet">

 <link xlink:type="simple" xlink:href="../948/105948.xml">
Essential fatty acid</link> style="background:#f9f9f9; font-size:85%; line-height:110%; "</entry>
</list>

| <image width="50x28px" src="Bananen.jpg">
</image>

| style="padding:0 0.2em;" | <b><it>
Food&#32;portal</it></b>
|}</col>
</row>
</table>

<b><it>n</it></b><b>−3 fatty acids</b> (popularly referred to as <b>ω−3 fatty acids</b> or <b>omega-3 fatty acids</b>) are a family of <link xlink:type="simple" xlink:href="../748/264748.xml">
unsaturated</link> <link xlink:type="simple" xlink:href="../975/10975.xml">
fatty acid</link>s that have in common a carbon–carbon <link xlink:type="simple" xlink:href="../246/6246.xml#xpointer(//*[./st=%22Bond+order%22])">
double bond</link> in the <link xlink:type="simple" xlink:href="../948/105948.xml#xpointer(//*[./st=%22Nomenclature+and+terminology%22])">
<it>n</it>−3</link> position; that is, the third bond from the <link xlink:type="simple" xlink:href="../839/19839.xml">
methyl</link> end of the fatty acid.</p>
<p>

Important nutritionally essential <it>n</it>−3 fatty acids are: <link xlink:type="simple" xlink:href="../316/153316.xml">
α-linolenic acid</link> (ALA), <link xlink:type="simple" xlink:href="../775/1593775.xml">
eicosapentaenoic acid</link> (EPA), and <link xlink:type="simple" xlink:href="../318/1673318.xml">
docosahexaenoic acid</link> (DHA). The human body cannot synthesize <it>n</it>−3 fatty acids <it><link xlink:type="simple" xlink:href="../575/5670575.xml">
de novo</link></it>, but it can form 20- and 22-carbon unsaturated <it>n</it>−3 fatty acids from the eighteen-carbon <it>n</it>−3 fatty acid, α-linolenic acid. These conversions occur competitively with <it>n</it>−6 fatty acids, which are essential closely related chemical analogues that are derived from linoleic acid. Both the <it>n</it>−3 α-linolenic acid and <it>n</it>−6 linoleic acid are <link xlink:type="simple" xlink:href="../854/529854.xml">
essential nutrients</link> which must be obtained from food. Synthesis of the longer <it>n</it>−3 fatty acids from linolenic acid within the body is competitively slowed by the <it>n</it>−6 analogues. Thus accumulation of long-chain <it>n</it>−3 fatty acids in tissues is more effective when they are obtained directly from food or when competing amounts of <it>n</it>−6 analogs do not greatly exceed the amounts of <it>n</it>−3.</p>

<sec>
<st>
 Chemistry </st>
<p>

<image location="right" width="360px" src="ALAnumbering.svg" type="thumb">
<caption>

Chemical structure of alpha-linolenic acid (ALA), an essential <it>n</it>−3 fatty acid, (18:3Δ9c,12c,15c, which means a chain of 18 carbons with 3 double bonds on carbons numbered 9, 12 and 15). Although chemists count from the carbonyl carbon (blue numbering), physiologists count from the <it>n</it> (ω) carbon (red numbering). Note that from the <it>n</it> end (diagram right), the first double bond appears as the third carbon-carbon bond (line segment), hence the name "<it>n</it>−3". This is explained by the fact that the <it>n</it> end is almost never changed during physiologic transformations in the human body, as it is more stable energetically, and other carbohydrates compounds can be synthetized from the other carbonyl end, for example in glycrids, or from double bonds in the middle of the chain.
</caption>
</image>
</p>
<p>

The term <b><it>n</it></b><b>−3</b> (also called <b>ω−3</b> or <b>omega-3</b>) signifies that the first <link xlink:type="simple" xlink:href="../246/6246.xml">
double bond</link> exists as the <b>third</b> carbon-carbon bond from the terminal <link xlink:type="simple" xlink:href="../839/19839.xml">
methyl</link> end (<it>n</it>) of the <link xlink:type="simple" xlink:href="../299/5299.xml">
carbon chain</link>.</p>
<p>

<it>n</it>−3 fatty acids which are important in human nutrition are: α-linolenic acid (18:3, <it>n</it>−3; ALA), eicosapentaenoic acid (20:5, <it>n</it>−3; EPA), and docosahexaenoic acid (22:6, <it>n</it>−3; DHA). These three <link xlink:type="simple" xlink:href="../513/1610513.xml">
polyunsaturates</link> have either 3, 5 or 6 double bonds in a carbon chain of 18, 20 or 22 carbon atoms, respectively. All double bonds are in the <it><link xlink:type="simple" xlink:href="../445/9130445.xml">
cis</link></it>-configuration, i.e. the two hydrogen atoms are on the same side of the double bond.</p>
<p>

Most naturally-produced fatty acids (created or transformed in animalia or plant cells with an even number of carbon in chains) are in <it>cis</it>-configuration where they are more easily transformable. The <it>trans</it>-configuration results in much more stable chains that are very difficult to further break or transform, forming longer chains that aggregate in tissues and lacking the necessary hydrophilic properties. This <it>trans</it>-configuration can be the result of the transformation in alkaline solutions, or of the action of some bacterias that are shortening the carbonic chains. Natural transforms in vegetal or animal cells more rarely affect the last <it>n</it>−3 group itself. However, <it>n</it>−3 compounds are still more fragile than <it>n</it>−6 because the last double bond is geometrically and electrically more exposed, notably in the natural <it>cis</it> configuration.</p>


<ss1>
<st>
List of <it>n</it>−3 fatty acids</st>
<p>

This table lists several different names for the most common <it>n</it>−3 fatty acids found in nature.
<table class="wikitable">
<header>
Common name</header>
<header>
Lipid name</header>
<header>
Chemical name</header>
<row>

<col>
16:3 (<it>n</it>−3)</col>
<col>
<it>all</it>-<it>cis</it>-7,10,13-hexadecatrienoic acid</col>
</row>
<row>
<col>
 <link xlink:type="simple" xlink:href="../316/153316.xml">
α-Linolenic acid</link>(ALA)</col>
<col>
18:3 (<it>n</it>−3)</col>
<col>
<it>all</it>-<it>cis</it>-9,12,15-octadecatrienoic acid</col>
</row>
<row>
<col>
 <link xlink:type="simple" xlink:href="../140/3956140.xml">
Stearidonic acid</link>(STD)</col>
<col>
18:4 (<it>n</it>−3)</col>
<col>
<it>all</it>-<it>cis</it>-6,9,12,15-octadecatetraenoic acid</col>
</row>
<row>
<col>
 <link>
Eicosatrienoic acid</link>(ETE)</col>
<col>
20:3 (<it>n</it>−3)</col>
<col>
<it>all</it>-<it>cis</it>-11,14,17-eicosatrienoic acid</col>
</row>
<row>
<col>
 <link xlink:type="simple" xlink:href="../527/4163527.xml">
Eicosatetraenoic acid</link>(ETA)</col>
<col>
20:4 (<it>n</it>−3)</col>
<col>
<it>all</it>-<it>cis</it>-8,11,14,17-eicosatetraenoic acid</col>
</row>
<row>
<col>
 <link xlink:type="simple" xlink:href="../775/1593775.xml">
Eicosapentaenoic acid</link>(EPA)</col>
<col>
20:5 (<it>n</it>−3)</col>
<col>
<it>all</it>-<it>cis</it>-5,8,11,14,17-eicosapentaenoic acid</col>
</row>
<row>
<col>
 <link xlink:type="simple" xlink:href="../751/6771751.xml">
Docosapentaenoic acid</link>(DPA),Clupanodonic acid</col>
<col>
22:5 (<it>n</it>−3)</col>
<col>
<it>all</it>-<it>cis</it>-7,10,13,16,19-docosapentaenoic acid</col>
</row>
<row>
<col>
 <link xlink:type="simple" xlink:href="../318/1673318.xml">
Docosahexaenoic acid</link>(DHA)</col>
<col>
22:6 (<it>n</it>−3)</col>
<col>
<it>all</it>-<it>cis</it>-4,7,10,13,16,19-docosahexaenoic acid</col>
</row>
<row>
<col>
 <link>
Tetracosapentaenoic acid</link></col>
<col>
24:5 (<it>n</it>−3)</col>
<col>
<it>all</it>-<it>cis</it>-9,12,15,18,21-docosahexaenoic acid</col>
</row>
<row>
<col>
 <link>
Tetracosahexaenoic acid</link>(Nisinic acid)</col>
<col>
24:6 (<it>n</it>−3)</col>
<col>
<it>all</it>-<it>cis</it>-6,9,12,15,18,21-tetracosenoic acid</col>
</row>
</table>
</p>

</ss1>
</sec>
<sec>
<st>
Biological significances</st>
<p>

<indent level="1">

<it>The biological effects of the </it>n<it>−3 are largely mediated by their interactions with the </it>n<it>−6 fatty acids; see <link xlink:type="simple" xlink:href="../714/4576714.xml">
Essential fatty acid interactions</link> for detail.</it>
</indent>

A <link xlink:type="simple" xlink:href="../669/34669.xml">
1992</link> article by <link xlink:type="simple" xlink:href="../954/3954.xml">
biochemist</link> <person wordnetid="100007846" confidence="0.9638700866880419">
<link xlink:type="simple" xlink:href="../903/13167903.xml">
William E.M. Lands</link></person>
<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%221%22])">1</ref> provides an overview of the research into <it>n</it>−3 fatty acids, and is the basis of this section.</p>
<p>

The 'essential' fatty acids were given their name when researchers found that they were essential to normal growth in young children and animals. (Note that the modern definition of '<link xlink:type="simple" xlink:href="../948/105948.xml">
essential'</link> is more strict.) A small amount of <it>n</it>−3 in the diet (~1% of total calories) enabled normal growth, and increasing the amount had little to no additional effect on growth.</p>
<p>

Likewise, researchers found that <link xlink:type="simple" xlink:href="../218/681218.xml">
<it>n</it>−6 fatty acids</link> (such as <link xlink:type="simple" xlink:href="../075/806075.xml">
γ-linolenic acid</link> and <link xlink:type="simple" xlink:href="../909/267909.xml">
arachidonic acid</link>) play a similar role in normal growth. However, they also found that <it>n</it>−6 was "better" at supporting <link xlink:type="simple" xlink:href="../480/740480.xml">
dermal</link> integrity, <link xlink:type="simple" xlink:href="../025/17025.xml">
renal</link> function, and <link xlink:type="simple" xlink:href="../449/83449.xml">
parturition</link>. These preliminary findings led researchers to concentrate their studies on <it>n</it>−6, and it was only in recent decades that <it>n</it>−3 has become of interest.</p>
<p>

In 1963 it was discovered that the <it>n</it>−6 arachidonic acid was converted by the body into <link xlink:type="simple" xlink:href="../425/70425.xml">
pro-inflammatory</link> agents called <link xlink:type="simple" xlink:href="../336/92336.xml">
prostaglandin</link>s. By 1979 more of what are now known as <link xlink:type="simple" xlink:href="../312/631312.xml">
eicosanoid</link>s were discovered: <link xlink:type="simple" xlink:href="../732/900732.xml">
thromboxane</link>s, <link xlink:type="simple" xlink:href="../223/899223.xml">
prostacyclin</link>s and the <link xlink:type="simple" xlink:href="../155/825155.xml">
leukotriene</link>s. The eicosanoids, which have important biological functions, typically have a short active lifetime in the body, starting with synthesis from fatty acids and ending with metabolism by enzymes. However, if the rate of synthesis exceeds the rate of metabolism, the excess eicosanoids may have deleterious effects. Researchers found that <it>n</it>−3 is also converted into eicosanoids, but at a much slower rate. Eicosanoids made from <it>n</it>−3 fats often have opposing functions to those made from <it>n</it>−6 fats (ie, anti-inflammatory rather than inflammatory). If both <it>n</it>−3 and <it>n</it>−6 are present, they will "compete" to be transformed, so the ratio of <it>n</it>−3:<it>n</it>−6 directly affects the type of eicosanoids that are produced.</p>
<p>

This competition was recognized as important when it was found that <link xlink:type="simple" xlink:href="../732/900732.xml">
thromboxane</link> is a factor in the clumping of <link xlink:type="simple" xlink:href="../121/196121.xml">
platelet</link>s, which leads to <link xlink:type="simple" xlink:href="../048/183048.xml">
thrombosis</link>. The <link xlink:type="simple" xlink:href="../155/825155.xml">
leukotriene</link>s were similarly found to be important in immune/inflammatory-system response, and therefore relevant to <link xlink:type="simple" xlink:href="../776/1776.xml">
arthritis</link>, <link xlink:type="simple" xlink:href="../427/18427.xml">
lupus</link>, and <link xlink:type="simple" xlink:href="../905/44905.xml">
asthma</link>. These discoveries led to greater interest in finding ways to control the synthesis of <it>n</it>−6 eicosanoids. The simplest way would be by consuming more <it>n</it>−3 and fewer <it>n</it>−6 fatty acids.</p>

</sec>
<sec>
<st>
Health benefits</st>
<p>

On <link xlink:type="simple" xlink:href="../488/28488.xml">
September 8</link>, <link xlink:type="simple" xlink:href="../524/35524.xml">
2004</link>, the U.S. <link xlink:type="simple" xlink:href="../632/11632.xml">
Food and Drug Administration</link> gave "qualified health claim" status to eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) <it>n</it>−3 fatty acids, stating that "supportive but not conclusive research shows that consumption of EPA and DHA [''n''−3] fatty acids may reduce the risk of <link xlink:type="simple" xlink:href="../735/5069735.xml">
coronary heart disease</link>."<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%222%22])">2</ref> This updated and modified their health risk advice letter of 2001 (see below).</p>
<p>

People with certain circulatory problems, such as <link xlink:type="simple" xlink:href="../834/32834.xml">
varicose veins</link>, benefit from <link xlink:type="simple" xlink:href="../306/999306.xml">
fish oil</link>. Fish oil stimulates <link xlink:type="simple" xlink:href="../330/57330.xml">
blood circulation</link>, increases the breakdown of <link xlink:type="simple" xlink:href="../685/238685.xml">
fibrin</link>, a compound involved in clot and scar formation, and additionally has been shown to reduce <link xlink:type="simple" xlink:href="../558/56558.xml">
blood pressure</link>.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%223%22])">3</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%224%22])">4</ref>
There is strong scientific evidence that <it>n</it>−3 fatty acids significantly reduce <link xlink:type="simple" xlink:href="../997/3997.xml">
blood</link> <link xlink:type="simple" xlink:href="../525/56525.xml">
triglyceride</link> levels<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%225%22])">5</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%226%22])">6</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%227%22])">7</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%228%22])">8</ref> and regular intake reduces the risk of secondary and primary <link xlink:type="simple" xlink:href="../969/60969.xml">
heart attack</link>.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%229%22])">9</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2210%22])">10</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2211%22])">11</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2212%22])">12</ref></p>
<p>

Some benefits have been reported in conditions such as rheumatoid <link xlink:type="simple" xlink:href="../776/1776.xml">
arthritis</link><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2213%22])">13</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2214%22])">14</ref> and cardiac arrhythmias.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2215%22])">15</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2216%22])">16</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2217%22])">17</ref></p>
<p>

There is a promising preliminary evidence that <it>n</it>-3 fatty acids supplementation might be helpful in cases of <disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../389/8389.xml">
depression</link></disease>
<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2218%22])">18</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2219%22])">19</ref> and anxiety.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2220%22])">20</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2221%22])">21</ref> Studies report highly significant improvement from <it>n</it>-3 fatty acids supplementation alone and in conjunction with medication.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2222%22])">22</ref></p>
<p>

Some research suggests that <link xlink:type="simple" xlink:href="../306/999306.xml">
fish oil</link> intake may reduce the risk of ischemic and thrombotic <link xlink:type="simple" xlink:href="../404/625404.xml">
stroke</link>.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2223%22])">23</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2224%22])">24</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2225%22])">25</ref> However, very large amounts may actually increase the risk of hemorrhagic stroke (see below). Lower amounts are not related to this risk,<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2225%22])">25</ref> 3 grams of total EPA/DHA daily are considered safe with no increased risk of bleeding involved<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2226%22])">26</ref> and many studies used substantially higher doses without major side effects (for example: 4.4 grams EPA/2.2 grams DHA in 2003 study).<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2218%22])">18</ref></p>
<p>

Several studies report possible anti-<link xlink:type="simple" xlink:href="../219/105219.xml">
cancer</link> effects of <it>n</it>−3 fatty acids (particularly breast, colon and prostate cancer).<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2227%22])">27</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2228%22])">28</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2229%22])">29</ref> No clear conclusion can be drawn at this time, however.</p>
<p>

A 2006 report in the <periodical wordnetid="106593296" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../941/541941.xml">
Journal of the American Medical Association</link></periodical>
 concluded that their review of literature covering <link xlink:type="simple" xlink:href="../271/397271.xml">
cohorts</link> from many countries with a wide variety of demographic characteristics demonstrating a link between <it>n</it>−3 fatty acids and <link xlink:type="simple" xlink:href="../219/105219.xml">
cancer</link> prevention gave mixed results.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2230%22])">30</ref> This is similar to the findings of a review by the <periodical wordnetid="106593296" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../927/541927.xml">
British Medical Journal</link></periodical>
 of studies up to February 2002 that failed to find clear effects of long and shorter chain <it>n</it>−3 fats on total <link xlink:type="simple" xlink:href="../015/196015.xml">
mortality</link>, combined cardiovascular events and cancer.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2231%22])">31</ref></p>
<p>

In 1999, the <link xlink:type="simple" xlink:href="../227/14330227.xml">
GISSI</link>-Prevenzione Investigators reported in <link xlink:type="simple" xlink:href="../899/463899.xml">
the Lancet</link>, the results of major clinical study in 11,324 patients with a recent myocardial infarction. Treatment 1 gram per day of <it>n</it>−3 fatty acids reduced the occurrence of death, cardiovascular death and sudden cardiac death by 20%, 30% and 45% respectively.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2232%22])">32</ref> These beneficial effects were seen already from three months onwards.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2233%22])">33</ref></p>
<p>

In April 2006, a team led by <link>
Lee Hooper</link> at the <university wordnetid="108286163" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../027/197027.xml">
University of East Anglia</link></university>
 in <region wordnetid="108630985" confidence="0.8">
<center wordnetid="108523483" confidence="0.8">
<area wordnetid="108497294" confidence="0.8">
<administrative_district wordnetid="108491826" confidence="0.8">
<seat wordnetid="108647945" confidence="0.8">
<location wordnetid="100027167" confidence="0.8">
<municipality wordnetid="108626283" confidence="0.8">
<geographical_area wordnetid="108574314" confidence="0.8">
<county_town wordnetid="108547300" confidence="0.8">
<district wordnetid="108552138" confidence="0.8">
<urban_area wordnetid="108675967" confidence="0.8">
<city wordnetid="108524735" confidence="0.8">
<link xlink:type="simple" xlink:href="../443/103443.xml">
Norwich</link></city>
</urban_area>
</district>
</county_town>
</geographical_area>
</municipality>
</location>
</seat>
</administrative_district>
</area>
</center>
</region>
, UK, published a review of almost 100 separate studies into <it>n</it>−3 fatty acids, found in abundance in oily fish. It concluded that they do not have a significant protective effect against cardiovascular disease.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2234%22])">34</ref> This meta-analysis was controversial and stands in stark contrast with two different reviews also performed in 2006 by the <link>
American Journal of Clinical Nutrition</link><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2235%22])">35</ref> and a second <periodical wordnetid="106593296" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../941/541941.xml">
JAMA</link></periodical>
 review<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2236%22])">36</ref> that both indicated decreases in total mortality and cardiovascular incidents (i.e. <link xlink:type="simple" xlink:href="../969/60969.xml">
myocardial infarction</link>s) associated with the regular consumption of fish and <link xlink:type="simple" xlink:href="../306/999306.xml">
fish oil</link> supplements. In addition <it>n</it>−3 has shown to aid in other mental disorders such as aggression and ADHD (<disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../976/64976.xml">
Attention-deficit hyperactivity disorder</link></disease>
).<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2237%22])">37</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2238%22])">38</ref></p>
<p>

Several studies published in 2007 have been more positive. In the March 2007 edition of the journal <link xlink:type="simple" xlink:href="../385/85385.xml">
<it>Atherosclerosis''</it></link>, 81 <link xlink:type="simple" xlink:href="../573/15573.xml">
Japan</link>ese men with unhealthy <link xlink:type="simple" xlink:href="../406/289406.xml">
blood sugar</link> levels were randomly assigned to receive 1800&nbsp;mg daily of eicosapentaenoic acid (EPA &mdash; an <it>n</it>−3 essential fatty acid from fish oil) with the other half being a control group. The thickness of the <link xlink:type="simple" xlink:href="../840/2591840.xml">
carotid arteries</link> and certain measures of blood flow were measured before and after supplementation. This went on for approximately two years. A total of 60 patients (30 in the EPA group and 30 in the control group) completed the study. Those given the EPA had a statistically significant decrease in the thickness of the carotid arteries along with improvement in blood flow. The authors indicated that this was the first demonstration that administration of purified EPA improves the thickness of <link xlink:type="simple" xlink:href="../840/2591840.xml">
carotid arteries</link> along with improving blood flow in patients with unhealthy blood sugar levels.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2239%22])">39</ref></p>
<p>

In another study published in the American Journal of Health System Pharmacy March 2007, patients with high <link xlink:type="simple" xlink:href="../525/56525.xml">
triglyceride</link>s and poor coronary artery health were given 4 grams a day of a combination of EPA and DHA along with some monounsaturated fatty acids. Those patients with very unhealthy <link xlink:type="simple" xlink:href="../525/56525.xml">
triglyceride</link> levels (above 500&nbsp;mg/dl) reduced their triglycerides on average 45% and their VLDL <link xlink:type="simple" xlink:href="../437/6437.xml">
cholesterol</link> by more than 50%. VLDL is a bad type of <link xlink:type="simple" xlink:href="../437/6437.xml">
cholesterol</link> and elevated <link xlink:type="simple" xlink:href="../525/56525.xml">
triglyceride</link>s can also be deleterious for cardiovascular health.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2240%22])">40</ref></p>
<p>

There was another study published on the benefits of EPA in <it>The Lancet</it> in March 2007. This study involved over 18,000 patients with unhealthy cholesterol levels. The patients were randomly assigned to receive either 1,800&nbsp;mg a day of EPA with a statin drug or a statin drug alone. The trial went on for a total of five years. It was found at the end of the study those patients in the EPA group had superior cardiovascular function. Non-fatal coronary events were also significantly reduced in the EPA group. The authors concluded that EPA is a promising treatment for prevention of major coronary events, especially non-fatal coronary events.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2241%22])">41</ref></p>
<p>

Another study regarding fish oil was published in the <it>Journal of Nutrition</it> in April 2007. Sixty four healthy Danish infants from nine to twelve months of age received either cow's milk or infant formula alone or with <link xlink:type="simple" xlink:href="../306/999306.xml">
fish oil</link>. It was found that those <link xlink:type="simple" xlink:href="../165/73165.xml">
infant</link>s supplemented with fish oil had improvement in <link xlink:type="simple" xlink:href="../547/298547.xml">
immune</link> function maturation with no apparent reduction in immune activation.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2242%22])">42</ref></p>
<p>

There was yet another study on <it>n</it>−3 fatty acids published in the April 2007 <it>Journal of Neuroscience</it>. A group of mice were genetically modified to develop accumulation of amyloid and tau proteins in the <link xlink:type="simple" xlink:href="../717/3717.xml">
brain</link> similar to that seen in people with poor memory. The mice were divided into four groups with one group receiving a typical American diet (with high ratio of <it>n</it>−6 to <it>n</it>−3 fatty acids being 10 to 1). The other three groups were given food with a balanced 1 to 1 <it>n</it>−6 to <it>n</it>−3 ratio and two additional groups supplemented with DHA plus long chain <it>n</it>−6 fatty acids. After three months of feeding, all the DHA supplemented groups were noted to have a lower accumulation of beta amyloid and tau protein. Some research suggests that these abnormal proteins may contribute to the development of memory loss in later years.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2243%22])">43</ref></p>
<p>

There is also a study published regarding <it>n</it>−3 supplementation in children with learning and behavioral problems. This study was published in the April 2007 edition of the <it>Journal of the Developmental and Behavioral Pediatrics</it> (5), where 132 children, between the ages of seven to twelve years old, with poor learning, participated in a randomized, <link xlink:type="simple" xlink:href="../821/142821.xml">
placebo</link>-controlled, <link xlink:type="simple" xlink:href="../248/277248.xml">
double-blinded</link> interventional trial. A total of 104 children completed the trial. For the first fifteen weeks of this study, the children were given polyunsaturated fatty acids (<it>n</it>−3 and <it>n</it>−6, 3000&nbsp;mg a day), polyunsaturated fatty acids plus multi-vitamins and minerals or placebo. After fifteen weeks, all groups crossed over to the polyunsaturated fatty acids (PUFA) plus vitamins and mineral supplement. Parents were asked to rate their children's condition after fifteen and thirty weeks. After thirty weeks, parental ratings of behavior improved significantly in nine out of fourteen scales. The lead author of the study, Dr. Sinn, indicated the present study is the largest PUFA trial to date with children falling in the poor learning and focus range. The results support those of other studies that have found improvement in poor developmental health with essential <link xlink:type="simple" xlink:href="../975/10975.xml">
fatty acid</link> supplementation.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2240%22])">40</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2241%22])">41</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2242%22])">42</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2243%22])">43</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2244%22])">44</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2245%22])">45</ref></p>
<p>

Research in 2005 and 2006 has suggested that the in-vitro anti-inflammatory activity of <it>n</it>−3 acids translates into clinical benefits. Cohorts of neck pain patients and of rheumatoid arthritis sufferers have demonstrated benefits comparable to those receiving standard <link xlink:type="simple" xlink:href="../071/22071.xml">
NSAID</link>s. Those who follow a Mediterranean-style diet tend to have less heart disease, higher HDL ("good") cholesterol levels<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2246%22])">46</ref> and higher proportions of <it>n</it>−3 in tissue highly unsaturated fatty acids.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2247%22])">47</ref> Similar to those who follow a Mediterranean diet, Arctic-dwelling <ethnic_group wordnetid="107967382" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../166/15704166.xml">
Inuit</link></ethnic_group>
 - who consume high amounts of <it>n</it>−3 fatty acids from fatty fish - also tend to have higher proportions of <it>n</it>−3, increased HDL cholesterol and decreased <link xlink:type="simple" xlink:href="../525/56525.xml">
triglyceride</link>s (fatty material that circulates in the blood) and less heart disease. Eating <link xlink:type="simple" xlink:href="../140/165140.xml">
walnuts</link> (the ratio of <it>n</it>−3 to <it>n</it>−6 is circa 1:4 respectively<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2248%22])">48</ref>) was reported to lower total <link xlink:type="simple" xlink:href="../437/6437.xml">
cholesterol</link> by 4% relative to controls when people also ate 27% less cholesterol.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2249%22])">49</ref></p>
<p>

A study<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2250%22])">50</ref> examining whether omega-3 exerts neuroprotective action in <link xlink:type="simple" xlink:href="../185/6302185.xml">
Parkinson's disease</link> found that it did, using an experimental model, exhibit a protective effect (much like it did for <link xlink:type="simple" xlink:href="../017/18914017.xml">
Alzheimer's disease</link> as well). The scientists exposed mice to either a control or a high omega-3 diet from two to twelve months of age and then treated them with a neurotoxin commonly used as an experimental model for Parkinson's. The scientists found that high doses of omega-3 given to the experimental group completely prevented the <link xlink:type="simple" xlink:href="../357/326357.xml">
neurotoxin</link>-induced decrease of dopamine that ordinarily occurs. Since Parkinson's is a disease caused by disruption of the <link xlink:type="simple" xlink:href="../548/48548.xml">
dopamine</link> system, this protective effect exhibited could show promise for future research in the prevention of Parkinson's disease.</p>
<p>

A study carried out involving 465 women showed serum levels of <link xlink:type="simple" xlink:href="../775/1593775.xml">
eicosapentaenoic acid</link> is inversely related to the levels of anti-oxidized-<link xlink:type="simple" xlink:href="../521/51521.xml">
LDL</link> antibodies. Oxidative modification of LDL is thought to play an important role in the development of <link xlink:type="simple" xlink:href="../385/85385.xml">
atherosclerosis</link>.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2251%22])">51</ref></p>
<p>

In 2008 a German study suggested that Omega-3 fatty acids have a positive effect on <link xlink:type="simple" xlink:href="../073/2225073.xml">
atopic dermatitis</link>.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2252%22])">52</ref></p>

</sec>
<sec>
<st>
 Health risks </st>
<p>

In a letter published <link xlink:type="simple" xlink:href="../437/22437.xml">
October 31</link>, <link xlink:type="simple" xlink:href="../548/34548.xml">
2000</link>,<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2253%22])">53</ref> the United States <link xlink:type="simple" xlink:href="../632/11632.xml">
Food and Drug Administration</link> Center for Food Safety and Applied Nutrition, Office of Nutritional Products, Labeling, and Dietary Supplements noted that known or suspected risks of EPA and DHA <it>n</it>−3 fatty acids may include the possibility of:
<list>
<entry level="1" type="bullet">

 Increased bleeding if overused (normally over 3 grams per day) by a patient who is also taking <link xlink:type="simple" xlink:href="../525/1525.xml">
aspirin</link> or <link xlink:type="simple" xlink:href="../097/238097.xml">
warfarin</link>. However, this is disputed.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2254%22])">54</ref></entry>
<entry level="1" type="bullet">

 <link xlink:type="simple" xlink:href="../404/625404.xml">
Hemorrhagic stroke</link> (only in case of very large doses). <ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2255%22])">55</ref></entry>
<entry level="1" type="bullet">

 Oxidation of <it>n</it>−3 fatty acids forming biologically active oxidation products.</entry>
<entry level="1" type="bullet">

 Reduced glycemic control among diabetics.</entry>
<entry level="1" type="bullet">

 Suppression of immune and inflammation responses, and consequently, decreased resistance to infections and increased susceptibility to opportunistic bacteria.</entry>
<entry level="1" type="bullet">

 An increase in concentration of LDL cholesterol in some individuals.</entry>
</list>

Subsequent advices from the FDA and national counterparts have permitted health claims associated with heart health.</p>

<ss1>
<st>
Cardiac risk</st>
<p>

Persons with <link xlink:type="simple" xlink:href="../930/249930.xml">
congestive heart failure</link>, chronic recurrent <link xlink:type="simple" xlink:href="../972/8144972.xml">
angina</link> or evidence that their heart is receiving insufficient blood flow are advised to talk to their doctor before taking <it>n</it>−3 fatty acids. There have been concerns if such persons take <it>n</it>−3 fatty acids or eating foods that contain them in substantial amounts.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2256%22])">56</ref> In a recent large study, <it>n</it>−3 fatty acids on top of standard heart failure therapy produced a small but statistically significant benefit in terms of mortality and hospitalization.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2257%22])">57</ref></p>
<p>

In congestive heart failure, cells that are only barely receiving enough blood flow become electrically hyperexcitable. This, in turn, can lead to increased risk of irregular heartbeats, which, in turn, can cause sudden cardiac death. <it>n</it>−3 fatty acids seem to stabilize the rhythm of the heart by effectively preventing these hyperexcitable cells from functioning, thereby reducing the likelihood of irregular heartbeats and sudden cardiac death. For most people, this is obviously beneficial and would account for most of the large reduction in the likelihood of sudden cardiac death. Nevertheless, for people with congestive heart failure, the heart is barely pumping blood well enough to keep them alive. In these patients, <it>n</it>−3 fatty acids may eliminate enough of these few pumping cells that the heart would no longer be able to pump sufficient blood to live, causing an increased risk of cardiac death.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2256%22])">56</ref></p>

</ss1>
</sec>
<sec>
<st>
Research frontiers</st>

<ss1>
<st>
Developmental differences</st>
<p>

Essential fatty acid supplements have gained popularity for children with <link xlink:type="simple" xlink:href="../976/64976.xml">
ADHD</link>, <link xlink:type="simple" xlink:href="../025/25.xml">
autism</link>, and other developmental differences.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2258%22])">58</ref> A 2004 Internet survey found that 29% of surveyed parents used essential fatty acid supplements to treat children with <link xlink:type="simple" xlink:href="../599/1517599.xml">
autism spectrum disorder</link>s.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2259%22])">59</ref></p>
<p>

Fish oils appear to reduce ADHD-related symptoms in some children.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2260%22])">60</ref> A 2007 double-blind, placebo-controlled trial of small groups of children found that omega-3 fatty acids reduced hyperactivity in children with <link xlink:type="simple" xlink:href="../599/1517599.xml">
autism spectrum disorder</link>s,<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2261%22])">61</ref> Additional double blind studies have showed "medium to strong treatment effects of omega 3 fatty acids on symptoms of ADHD."<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2238%22])">38</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2244%22])">44</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2237%22])">37</ref></p>

</ss1>
<ss1>
<st>
Low birth weight</st>
<p>

In a study of nearly 9,000 pregnant women, researchers found women who ate fish once a week during their first trimester had 3.6 times less risk of low birth weight and premature birth than those who ate no fish. Low consumption of fish was a strong risk factor for preterm delivery and low birth weight.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2262%22])">62</ref> However, attempts by other groups to reverse this increased risk by encouraging increased pre-natal consumption of fish were unsuccessful.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2263%22])">63</ref> This lead some researchers to consider that maybe women who ate fish in their first trimester were more likely to be able to afford better overall nutrition throughout pregnancy, and less likely to do drugs.</p>

</ss1>
<ss1>
<st>
 Psychiatric disorders </st>
<p>

<it>n</it>−3 fatty acids are known to have membrane-enhancing capabilities in brain cells.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2234%22])">34</ref> One medical explanation is that <it>n</it>−3 fatty acids play a role in the fortification of the <link xlink:type="simple" xlink:href="../319/19319.xml">
myelin sheaths</link>. Not coincidentally, <it>n</it>−3 fatty acids comprise approximately eight percent of the average human brain according to Dr. <physical_entity wordnetid="100001930" confidence="0.8">
<person wordnetid="100007846" confidence="0.8">
<causal_agent wordnetid="100007347" confidence="0.8">
<academician wordnetid="109759069" confidence="0.8">
<scientist wordnetid="110560637" confidence="0.8">
<adult wordnetid="109605289" confidence="0.8">
<professional wordnetid="110480253" confidence="0.8">
<research_worker wordnetid="110523076" confidence="0.8">
<educator wordnetid="110045713" confidence="0.8">
<link xlink:type="simple" xlink:href="../590/6995590.xml">
David Horrobin</link></educator>
</research_worker>
</professional>
</adult>
</scientist>
</academician>
</causal_agent>
</person>
</physical_entity>
, a pioneer in fatty acid research. <physical_entity wordnetid="100001930" confidence="0.8">
<person wordnetid="100007846" confidence="0.8">
<biochemist wordnetid="109854915" confidence="0.8">
<causal_agent wordnetid="100007347" confidence="0.8">
<scientist wordnetid="110560637" confidence="0.8">
<chemist wordnetid="109913824" confidence="0.8">
<link xlink:type="simple" xlink:href="../609/2648609.xml">
Ralph Holman</link></chemist>
</scientist>
</causal_agent>
</biochemist>
</person>
</physical_entity>
 of the <university wordnetid="108286163" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../813/416813.xml">
University of Minnesota</link></university>
, another major researcher in studying essential fatty acids, who gave Omega-3 its name, surmised how <it>n</it>−3 components are analogous to the human brain by stating that "DHA is structure, EPA is function."</p>
<p>

A benefit of <it>n</it>−3 fatty acids is helping the brain to repair damage by promoting neuronal growth.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2234%22])">34</ref> In a six-month study involving people with <link xlink:type="simple" xlink:href="../790/27790.xml">
schizophrenia</link> and <link xlink:type="simple" xlink:href="../878/47878.xml">
Huntington's disease</link> who were treated with EPA or a placebo, the placebo group had clearly lost cerebral tissue, while the patients given the supplements had a significant increase of grey and white matter.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2264%22])">64</ref></p>
<p>

In the <link xlink:type="simple" xlink:href="../493/1967493.xml">
prefrontal cortex</link> (PFC) of the <link xlink:type="simple" xlink:href="../717/3717.xml">
brain</link>, low brain <it>n</it>−3 fatty acids are thought to lower the dopaminergic <link xlink:type="simple" xlink:href="../988/2918988.xml">
neurotransmission</link> in this brain area, possibly contributing to the negative and neurocognitive symptoms in <link xlink:type="simple" xlink:href="../790/27790.xml">
schizophrenia</link>. This reduction in <link xlink:type="simple" xlink:href="../548/48548.xml">
dopamine</link> system function in the PFC may lead to an overactivity in dopaminergic function in the <link xlink:type="simple" xlink:href="../405/200405.xml">
limbic system</link> of the brain which is suppressively controlled by the PFC dopamine system, causing the positive symptoms of <link xlink:type="simple" xlink:href="../790/27790.xml">
schizophrenia</link>. This is called the <it>n</it>−3 polyunsaturated fatty acid/dopamine hypothesis of schizophrenia (Ohara, 2007). This mechanism may explain why <it>n</it>−3 supplementation shows effects against both positive, negative and neurocognitive <link xlink:type="simple" xlink:href="../967/196967.xml">
symptoms</link> in <link xlink:type="simple" xlink:href="../790/27790.xml">
schizophrenia</link>.</p>
<p>

Consequently, the past decade of <it>n</it>−3 fatty acid research has procured <it>some</it> <environment wordnetid="113934596" confidence="0.8">
<grouping wordnetid="101012360" confidence="0.8">
<event wordnetid="100029378" confidence="0.8">
<state wordnetid="100024720" confidence="0.8">
<sphere wordnetid="114514039" confidence="0.8">
<act wordnetid="100030358" confidence="0.8">
<situation wordnetid="113927383" confidence="0.8">
<psychological_feature wordnetid="100023100" confidence="0.8">
<activity wordnetid="100407535" confidence="0.8">
<categorization wordnetid="101012712" confidence="0.8">
<link xlink:type="simple" xlink:href="../892/18984892.xml">
Western</link></categorization>
</activity>
</psychological_feature>
</situation>
</act>
</sphere>
</state>
</event>
</grouping>
</environment>
 interest in <it>n</it>−3 fatty acids as being a legitimate 'brain food.' Still, recent claims that one's <link xlink:type="simple" xlink:href="../892/14892.xml">
intelligence quotient</link>, psychological tests measuring certain cognitive skills, including numerical and verbal reasoning skills, are increased on account of <it>n</it>−3 fatty acids consumed by pregnant mothers remain unreliable and controversial. An even more significant focus of research, however, lies in the role of <it>n</it>−3 fatty acids as a non-prescription treatment for certain psychiatric and mental diagnoses and has become a topic of much research and speculation.</p>
<p>

In 1998, Andrew L. Stoll, MD and his colleagues at <university wordnetid="108286163" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../501/18426501.xml">
Harvard University</link></university>
 conducted a small <link xlink:type="simple" xlink:href="../248/277248.xml">
double-blind</link> <link xlink:type="simple" xlink:href="../821/142821.xml">
placebo</link>-controlled study in thirty patients diagnosed with <link xlink:type="simple" xlink:href="../531/4531.xml">
bipolar disorder</link>. Most subjects in this study were already undergoing psychopharmacological treatment (e.g. 12 out of the 30 were taking lithium). Over the course of four months, he gave 15 subjects capsules containing <link xlink:type="simple" xlink:href="../478/22478.xml">
olive oil</link>, and another 15 subjects capsules containing nine grams of pharmaceutical-quality EPA and DHA. The study showed that subjects in the <it>n</it>−3 group were less likely to experience a relapse of symptoms in the four months of the study. Moreover, the <it>n</it>−3 group experienced significantly more recovery than the placebo group. However, a commentary on the Stoll study notes that the improvement in the <it>n</it>−3 group was too small to be clinically significant.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2265%22])">65</ref> Though Stoll believes that the 1999 experiment was not as optimal as it could have been and has accordingly pursued further research, the foundation has been laid for more researchers to explore the theoretical association between absorbed <it>n</it>−3 fatty acids and signal transduction inhibition in the brain.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2266%22])">66</ref></p>
<p>

"Several epidemiological studies suggest covariation between seafood consumption and rates of mood disorders. Biological marker studies indicate deficits in omega−3 fatty acids in people with depressive disorders, while several treatment studies indicate therapeutic benefits from omega-3 supplementation. A similar contribution of omega-3 fatty acids to coronary artery disease may explain the well-described links between coronary artery disease and depression. Deficits in omega-3 fatty acids have been identified as a contributing factor to mood disorders and offer a potential rational treatment approach."<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2267%22])">67</ref> In 2004, a study found that 100 suicide attempt patients on average had significantly lower levels of EPA in their blood as compared to controls.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2268%22])">68</ref></p>
<p>

In 2006, a review of published trials in the American Journal of Clinical Nutrition found that "the evidence available provides little support" for the use of fish or the n–3 long-chain polyunsaturated fatty acids contained in them to improve depressed mood. The study used results of twelve randomized controlled trials in its meta-analysis. The review recommended that "larger trials with adequate power to detect clinically important benefits" be performed.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2269%22])">69</ref> A further 2007 study published in the British Journal of Nutrition, which was placebo-controlled and used 218 participants, found that increasing EPA and DHA in the diet "was found not to have beneficial or harmful effects on mood in mild to moderate depression," confirming previous meta-analysis "that there is an overall negligible benefit of n-3 UFA supplementation for depressed mood". <ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2270%22])">70</ref></p>

</ss1>
</sec>
<sec>
<st>
 Dietary sources </st>

<ss1>
<st>
 Daily values </st>
<p>

As macronutrients, fats are not assigned <link xlink:type="simple" xlink:href="../054/396054.xml">
recommended daily allowance</link>s. Macronutrients have AI (Acceptable Intake) and AMDR (Acceptable Macronutrient Distribution Range) instead of RDAs. The AI for <it>n</it>−3 is 1.6 grams/day for men and 1.1 grams/day for women<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2271%22])">71</ref> while the AMDR is 0.6% to 1.2% of total energy.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2272%22])">72</ref></p>
<p>

"A growing body of literature suggests that higher intakes of α-linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) may afford some degree of protection against <link xlink:type="simple" xlink:href="../735/5069735.xml">
coronary heart disease</link>. Because the physiological potency of EPA and DHA is much greater than that for α-linolenic acid, it is not possible to estimate one AMDR for all <it>n</it>−3 fatty acids. Approximately 10 percent of the AMDR can be consumed as EPA and/or DHA."<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2272%22])">72</ref> There was insufficient evidence as of 2005 to set a UL (upper tolerable limit) for <it>n</it>−3 fatty acids.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2271%22])">71</ref></p>
<p>

Some researchers believe the ideal <link xlink:type="simple" xlink:href="../218/681218.xml">
<it>n</it>−6</link> intake should be no more than 4 to 5 times that of our <it>n</it>−3 intake. The National Institutes of Health recently published recommended daily intakes of fatty acids, specific recommendations include 650&nbsp;mg of EPA and DHA, 2.22 g/day of alpha-linolenic acid and 4.44 g/day of linoleic acid.</p>
<p>

A perceived risk of fish oil <it>n</it>−3 supplementation has been <link xlink:type="simple" xlink:href="../671/47671.xml">
heavy metal poisoning</link> by the body's accumulation of traces of heavy metals, in particular <mercury wordnetid="114645346" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../142/18617142.xml">
mercury</link></mercury>
, <link xlink:type="simple" xlink:href="../747/17747.xml">
lead</link>, <link xlink:type="simple" xlink:href="../274/21274.xml">
nickel</link>, <link xlink:type="simple" xlink:href="../897/897.xml">
arsenic</link> and <link xlink:type="simple" xlink:href="../672/5672.xml">
cadmium</link> as well as other contaminants (<link xlink:type="simple" xlink:href="../230/48230.xml">
PCBs</link>, <link xlink:type="simple" xlink:href="../505/546505.xml">
furan</link>s, <link xlink:type="simple" xlink:href="../142/13932142.xml">
dioxin</link>s), which potentially might be found especially in less-refined fish oil supplements. An independent test in 2006 of 44 fish oils on the US market found that all of the products passed safety standards for potential contaminants.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2273%22])">73</ref> The FDA recommends that total dietary intake of <it>n</it>−3 fatty acids from fish not exceed 3 grams per day, of which no more than 2 grams per day are from nutritional supplements.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%222%22])">2</ref></p>
<p>

Historically, the <link>
Council for Responsible Nutrition</link> (CRN) and the <organization wordnetid="108008335" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../583/33583.xml">
World Health Organization</link></organization>
 (WHO) have published acceptable standards regarding contaminants in fish oil. The most stringent current standard is the <link>
International Fish Oils Standard</link> (IFOS).
Fish oils that typically make this highest grade are those that are <link xlink:type="simple" xlink:href="../767/808767.xml">
molecularly distilled</link> under vacuum, and have virtually no measurable level of contaminants (measured parts per billion and parts per trillion).</p>
<p>

<it>n</it>−3 supplementation in food has been a significant recent trend in food fortification, with global food companies launching <it>n</it>−3 fortified bread, mayonnaise, pizza, yogurt, orange juice, children's pasta, milk, eggs, confections and infant formula.</p>

</ss1>
<ss1>
<st>
Fish</st>
<p>

The most widely available source of <link xlink:type="simple" xlink:href="../775/1593775.xml">
EPA</link> and <link xlink:type="simple" xlink:href="../318/1673318.xml">
DHA</link> is cold water oily fish such as <link xlink:type="simple" xlink:href="../984/36984.xml">
salmon</link>, <link xlink:type="simple" xlink:href="../890/49890.xml">
herring</link>, <link xlink:type="simple" xlink:href="../332/47332.xml">
mackerel</link>, <link xlink:type="simple" xlink:href="../741/234741.xml">
anchovies</link> and <link xlink:type="simple" xlink:href="../436/235436.xml">
sardine</link>s. Oils from these fish have a profile of around seven times as much <it>n</it>−3 as <it>n</it>−6. Other oily fish such as <link xlink:type="simple" xlink:href="../211/46211.xml">
tuna</link> also contain <it>n</it>−3 in somewhat lesser amounts. Consumers of oily fish should be aware of the potential presence of <link xlink:type="simple" xlink:href="../671/47671.xml">
heavy metals</link> and fat-soluble pollutants like <retardant wordnetid="109408250" confidence="0.8">
<physical_entity wordnetid="100001930" confidence="0.8">
<waste wordnetid="114856263" confidence="0.8">
<substance wordnetid="100020090" confidence="0.8">
<substance wordnetid="100019613" confidence="0.8">
<carcinogen wordnetid="114793812" confidence="0.8">
<causal_agent wordnetid="100007347" confidence="0.8">
<part wordnetid="113809207" confidence="0.8">
<agent wordnetid="109190918" confidence="0.8">
<pollutant wordnetid="114857278" confidence="0.8">
<material wordnetid="114580897" confidence="0.8">
<link xlink:type="simple" xlink:href="../230/48230.xml">
PCBs</link></material>
</pollutant>
</agent>
</part>
</causal_agent>
</carcinogen>
</substance>
</substance>
</waste>
</physical_entity>
</retardant>
 and <link xlink:type="simple" xlink:href="../142/13932142.xml">
dioxin</link>s which may <link xlink:type="simple" xlink:href="../503/59503.xml">
accumulate up the food chain</link>.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2274%22])">74</ref> Some supplement manufacturers remove heavy metals and other contaminants from the oil through various means, such as molecular distillation (see above), which increases purity, potency and safety.</p>
<p>

Even some forms of fish oil may not be optimally digestible. Of four studies that compare bioavailability of the triglyceride form of fish oil vs. the ester form, two have concluded that the natural triglyceride form is better, and the other two studies did not find a significant difference. No studies have shown the ester form to be superior although it is cheaper to manufacture.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2275%22])">75</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2276%22])">76</ref>  </p>
<p>

Although fish is a dietary source of <it>n</it>−3 fatty acids, fish do not synthesize them; they obtain them from the <link xlink:type="simple" xlink:href="../633/633.xml">
algae</link> in their diet.</p>

</ss1>
<ss1>
<st>
Flax</st>
<p>

<image width="250px" src="Flax_seeds.jpg" type="thumb">
</image>

Six times richer than most fish oils in <it>n</it>−3,<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2277%22])">77</ref> <link xlink:type="simple" xlink:href="../869/38869.xml">
Flax (aka linseed)</link> (<it>Linum usitatissimum</it>) and its oil are perhaps the most widely available <link xlink:type="simple" xlink:href="../183/4183.xml">
botanical</link> source of <it>n</it>−3. <link xlink:type="simple" xlink:href="../711/295711.xml">
Flaxseed oil</link> consists of approximately 55% ALA (alpha-linolenic acid). Flax, like <link xlink:type="simple" xlink:href="../860/3399860.xml">
chia</link>, contains approximately three times as much <it>n</it>−3 as <it>n</it>−6.</p>
<p>

15 grams of flaxseed oil provides ca. 8 grams of ALA, which is converted in the body to EPA and then DHA at an efficiency of 2–15% and 2–5%, respectively.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2278%22])">78</ref></p>

</ss1>
<ss1>
<st>
Botanical sources of <it>n</it>−3 fatty acids</st>
<p>

<b>Table 1.</b> <it>n</it>−3 content as the percentage of <link xlink:type="simple" xlink:href="../316/153316.xml">
ALA</link> in the seed oil.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2279%22])">79</ref>
<table style="border-collapse:collapse;" cellpadding="1" class="wikitable" border="1" cellspacing="0">
<header>
|Common name</header>
<row>
<col>
Alternative name</col>
<col>
<link xlink:type="simple" xlink:href="../581/53581.xml">
Linnaean name</link></col>
<col>
% <it>n</it>−3</col>
</row>
<row>
<col>
<link xlink:type="simple" xlink:href="../025/661025.xml">
Chia</link></col>
<col>
<link xlink:type="simple" xlink:href="../025/661025.xml">
chia sage</link></col>
<col>
<it><work wordnetid="100575741" confidence="0.8">
<commercial_enterprise wordnetid="101094725" confidence="0.8">
<transaction wordnetid="101106808" confidence="0.8">
<treatment wordnetid="100658082" confidence="0.8">
<medical_care wordnetid="100657604" confidence="0.8">
<production wordnetid="100913705" confidence="0.8">
<commerce wordnetid="101090446" confidence="0.8">
<crop wordnetid="113085864" confidence="0.8">
<group_action wordnetid="101080366" confidence="0.8">
<event wordnetid="100029378" confidence="0.8">
<care wordnetid="100654885" confidence="0.8">
<act wordnetid="100030358" confidence="0.8">
<industry wordnetid="100923444" confidence="0.8">
<output wordnetid="100914632" confidence="0.8">
<therapy wordnetid="100661091" confidence="0.8">
<psychological_feature wordnetid="100023100" confidence="0.8">
<activity wordnetid="100407535" confidence="0.8">
<link xlink:type="simple" xlink:href="../025/661025.xml">
Salvia hispanica</link></activity>
</psychological_feature>
</therapy>
</output>
</industry>
</act>
</care>
</event>
</group_action>
</crop>
</commerce>
</production>
</medical_care>
</treatment>
</transaction>
</commercial_enterprise>
</work>
''</it></col>
<col>
64</col>
</row>
<row>
<col>
<link xlink:type="simple" xlink:href="../363/17363.xml">
Kiwifruit</link></col>
<col>
<link xlink:type="simple" xlink:href="../363/17363.xml">
Chinese gooseberry</link></col>
<col>
<it><plant wordnetid="103956922" confidence="0.8">
<structure wordnetid="104341686" confidence="0.8">
<artifact wordnetid="100021939" confidence="0.8">
<building_complex wordnetid="102914991" confidence="0.8">
<link xlink:type="simple" xlink:href="../884/13714884.xml">
Actinidia chinensis</link></building_complex>
</artifact>
</structure>
</plant>
''</it></col>
<col>
62</col>
</row>
<row>
<col>
<link xlink:type="simple" xlink:href="../880/312880.xml">
Perilla</link></col>
<col>
<link xlink:type="simple" xlink:href="../525/494525.xml">
shiso</link></col>
<col>
<it><link xlink:type="simple" xlink:href="../811/2406811.xml">
Perilla frutescens</link>''</it></col>
<col>
58</col>
</row>
<row>
<col>
<link xlink:type="simple" xlink:href="../869/38869.xml">
Flax</link></col>
<col>
<link xlink:type="simple" xlink:href="../869/38869.xml">
linseed</link></col>
<col>
<it><link xlink:type="simple" xlink:href="../869/38869.xml">
Linum usitatissimum</link>''</it></col>
<col>
55</col>
</row>
<row>
<col>
<link xlink:type="simple" xlink:href="../288/4285288.xml">
Lingonberry</link></col>
<col>
<link xlink:type="simple" xlink:href="../288/4285288.xml">
Cowberry</link></col>
<col>
<it><link xlink:type="simple" xlink:href="../942/151942.xml">
Vaccinium vitis-idaea</link>''</it></col>
<col>
49</col>
</row>
<row>
<col>
<group_action wordnetid="101080366" confidence="0.8">
<commercial_enterprise wordnetid="101094725" confidence="0.8">
<transaction wordnetid="101106808" confidence="0.8">
<event wordnetid="100029378" confidence="0.8">
<output wordnetid="100914632" confidence="0.8">
<industry wordnetid="100923444" confidence="0.8">
<act wordnetid="100030358" confidence="0.8">
<psychological_feature wordnetid="100023100" confidence="0.8">
<production wordnetid="100913705" confidence="0.8">
<crop wordnetid="113085864" confidence="0.8">
<commerce wordnetid="101090446" confidence="0.8">
<link xlink:type="simple" xlink:href="../683/1910683.xml">
Camelina</link></commerce>
</crop>
</production>
</psychological_feature>
</act>
</industry>
</output>
</event>
</transaction>
</commercial_enterprise>
</group_action>
</col>
<col>
<link xlink:type="simple" xlink:href="../683/1910683.xml">
Gold-of-pleasure</link></col>
<col>
<it><group_action wordnetid="101080366" confidence="0.8">
<commercial_enterprise wordnetid="101094725" confidence="0.8">
<transaction wordnetid="101106808" confidence="0.8">
<event wordnetid="100029378" confidence="0.8">
<output wordnetid="100914632" confidence="0.8">
<industry wordnetid="100923444" confidence="0.8">
<act wordnetid="100030358" confidence="0.8">
<psychological_feature wordnetid="100023100" confidence="0.8">
<production wordnetid="100913705" confidence="0.8">
<crop wordnetid="113085864" confidence="0.8">
<commerce wordnetid="101090446" confidence="0.8">
<link xlink:type="simple" xlink:href="../683/1910683.xml">
Camelina sativa</link></commerce>
</crop>
</production>
</psychological_feature>
</act>
</industry>
</output>
</event>
</transaction>
</commercial_enterprise>
</group_action>
''</it></col>
<col>
36</col>
</row>
<row>
<col>
<link xlink:type="simple" xlink:href="../752/862752.xml">
Purslane</link></col>
<col>
<link xlink:type="simple" xlink:href="../752/862752.xml">
Portulaca</link></col>
<col>
<it><plant wordnetid="100017222" confidence="0.8">
<solid wordnetid="115046900" confidence="0.8">
<vascular_plant wordnetid="113083586" confidence="0.8">
<food wordnetid="107555863" confidence="0.8">
<weed wordnetid="113085113" confidence="0.8">
<vegetable wordnetid="107707451" confidence="0.8">
<produce wordnetid="107705711" confidence="0.8">
<link xlink:type="simple" xlink:href="../740/862740.xml">
Portulaca oleracea</link></produce>
</vegetable>
</weed>
</food>
</vascular_plant>
</solid>
</plant>
''</it></col>
<col>
35</col>
</row>
<row>
<col>
<plant wordnetid="103956922" confidence="0.8">
<structure wordnetid="104341686" confidence="0.8">
<artifact wordnetid="100021939" confidence="0.8">
<building_complex wordnetid="102914991" confidence="0.8">
<link xlink:type="simple" xlink:href="../815/1097815.xml">
Black Raspberry</link></building_complex>
</artifact>
</structure>
</plant>
</col>

<col>
<it><plant wordnetid="103956922" confidence="0.8">
<structure wordnetid="104341686" confidence="0.8">
<artifact wordnetid="100021939" confidence="0.8">
<building_complex wordnetid="102914991" confidence="0.8">
<link xlink:type="simple" xlink:href="../815/1097815.xml">
Rubus occidentalis</link></building_complex>
</artifact>
</structure>
</plant>
''</it></col>
<col>
33</col>
</row>
</table>
</p>
<p>

<b>Table 2.</b> <it>n</it>−3 content as the percentage of <link xlink:type="simple" xlink:href="../316/153316.xml">
ALA</link> in the whole food.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2280%22])">80</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2281%22])">81</ref>
<table style="border-collapse:collapse;" cellpadding="1" class="wikitable" border="1" cellspacing="0">
<header>
|Common name</header>
<row>
<col>
<link xlink:type="simple" xlink:href="../581/53581.xml">
Linnaean name</link></col>
<col>
% <it>n</it>−3</col>
</row>
<row>
<col>
<link xlink:type="simple" xlink:href="../869/38869.xml">
Flaxseed</link></col>
<col>
<it><link xlink:type="simple" xlink:href="../869/38869.xml">
Linum usitatissimum</link>''</it></col>
<col>
18.1</col>
</row>
<row>
<col>
<link xlink:type="simple" xlink:href="../264/4504264.xml">
Butternuts</link></col>
<col>
<it><plant_part wordnetid="113086908" confidence="0.8">
<plant wordnetid="100017222" confidence="0.8">
<fruit wordnetid="113134947" confidence="0.8">
<tree wordnetid="113104059" confidence="0.8">
<vascular_plant wordnetid="113083586" confidence="0.8">
<edible_nut wordnetid="107737081" confidence="0.8">
<seed wordnetid="113135832" confidence="0.8">
<reproductive_structure wordnetid="111675842" confidence="0.8">
<natural_object wordnetid="100019128" confidence="0.8">
<woody_plant wordnetid="113103136" confidence="0.8">
<nut wordnetid="113136556" confidence="0.8">
<plant_organ wordnetid="113087625" confidence="0.8">
<link xlink:type="simple" xlink:href="../076/1271076.xml">
Juglans cinerea</link></plant_organ>
</nut>
</woody_plant>
</natural_object>
</reproductive_structure>
</seed>
</edible_nut>
</vascular_plant>
</tree>
</fruit>
</plant>
</plant_part>
''</it></col>
<col>
8.7</col>
</row>
<row>
<col>
<link xlink:type="simple" xlink:href="../140/165140.xml">
Walnuts</link></col>
<col>
<it><plant wordnetid="103956922" confidence="0.8">
<structure wordnetid="104341686" confidence="0.8">
<artifact wordnetid="100021939" confidence="0.8">
<building_complex wordnetid="102914991" confidence="0.8">
<link xlink:type="simple" xlink:href="../502/1530502.xml">
Juglans regia</link></building_complex>
</artifact>
</structure>
</plant>
''</it></col>
<col>
6.3</col>
</row>
<row>
<col>
<link xlink:type="simple" xlink:href="../734/195734.xml">
Pecan</link>nuts</col>
<col>
<it><link xlink:type="simple" xlink:href="../734/195734.xml">
Carya illinoinensis</link>''</it></col>
<col>
0.6</col>
</row>
<row>
<col>
<link xlink:type="simple" xlink:href="../686/396686.xml">
Hazel</link>nuts</col>
<col>
<it><plant_part wordnetid="113086908" confidence="0.8">
<plant wordnetid="100017222" confidence="0.8">
<fruit wordnetid="113134947" confidence="0.8">
<tree wordnetid="113104059" confidence="0.8">
<vascular_plant wordnetid="113083586" confidence="0.8">
<edible_nut wordnetid="107737081" confidence="0.8">
<seed wordnetid="113135832" confidence="0.8">
<reproductive_structure wordnetid="111675842" confidence="0.8">
<natural_object wordnetid="100019128" confidence="0.8">
<woody_plant wordnetid="113103136" confidence="0.8">
<nut wordnetid="113136556" confidence="0.8">
<plant_organ wordnetid="113087625" confidence="0.8">
<link xlink:type="simple" xlink:href="../546/484546.xml">
Corylus avellana</link></plant_organ>
</nut>
</woody_plant>
</natural_object>
</reproductive_structure>
</seed>
</edible_nut>
</vascular_plant>
</tree>
</fruit>
</plant>
</plant_part>
''</it></col>
<col>
0.1</col>
</row>
</table>
</p>

</ss1>
<ss1>
<st>
 Eggs </st>
<p>

<link xlink:type="simple" xlink:href="../010/19196010.xml">
Eggs</link> produced by chickens fed a diet of greens and insects produce higher levels of <it>n</it>−3 fatty acids (mostly ALA) than chickens fed corn or soybeans.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2282%22])">82</ref>In addition to feeding chickens insects and greens, fish oils may be added to their diet to increase the amount of fatty acid concentrations in eggs.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2283%22])">83</ref></p>

</ss1>
<ss1>
<st>
Meat</st>
<p>

The <it>n</it>−6 to <it>n</it>−3 ratio of <link xlink:type="simple" xlink:href="../768/1059768.xml">
grass-fed</link> beef is about 2:1, making it a more useful source of <it>n</it>−3 than grain-fed beef, which usually has a ratio of 4:1.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2284%22])">84</ref> </p>
<p>

Commercially available <link xlink:type="simple" xlink:href="../563/17158563.xml">
lamb</link> is almost always grass-fed, and subsequently higher in <it>n</it>−3 than other common meat sources.</p>
<p>

The omega-3 content of <link xlink:type="simple" xlink:href="../402/37402.xml">
chicken</link> meat may be enhanced by increasing the animals' dietary intake of grains such as flax, chia, and canola.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2285%22])">85</ref></p>

</ss1>
<ss1>
<st>
 Other sources </st>
<p>

<link xlink:type="simple" xlink:href="../714/19714.xml">
Milk</link> and <link xlink:type="simple" xlink:href="../910/11749910.xml">
cheese</link> from grass-fed cows may also be good sources of <it>n</it>−3. One UK study showed that half a pint of milk provides 10% of the recommended daily intake (RDI) of ALA, while a piece of organic cheese the size of a matchbox may provide up to 88%".<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2286%22])">86</ref></p>
<p>

<link xlink:type="simple" xlink:href="../145/231145.xml">
Krill</link>, which are small, shrimp-like <link xlink:type="simple" xlink:href="../558/50558.xml">
zooplankton</link>, also contain the <it>n</it>−3 fatty acids EPA and DHA. One advantage of extracting <it>n</it>−3 fatty acids from krill, as opposed to sources higher in the food chain, is that krill contain fewer heavy metals and PCBs harmful to humans. However, in comparison to higher animals, they also contain fewer <it>n</it>−3 fatty acids per gram.</p>
<p>

The <link xlink:type="simple" xlink:href="../768/6983768.xml">
microalgae</link> <it>Crypthecodinium cohnii</it> and <it>Schizochytrium</it> are rich sources of <link xlink:type="simple" xlink:href="../318/1673318.xml">
DHA</link> (22:6 <it>n</it>−3) and can be produced commercially in <link xlink:type="simple" xlink:href="../670/616670.xml">
bioreactor</link>s. Oil from <link xlink:type="simple" xlink:href="../271/233271.xml">
brown algae</link> (kelp) is a source of EPA. <link xlink:type="simple" xlink:href="../140/165140.xml">
Walnuts</link> are one of few nuts that contain appreciable <it>n</it>−3 fat, with approximately a 1:4 ratio of <it>n</it>−3 to <it>n</it>−6.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2248%22])">48</ref> <link xlink:type="simple" xlink:href="../717/1455717.xml">
Acai</link> palm fruit also contains <it>n</it>−3 fatty acids.</p>
<p>

Omega 3 is also found in softgels in pharmacies and nowadays it is also found in combination with omega 6, omega 9 and shark liver oil <ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2287%22])">87</ref></p>

</ss1>
</sec>
<sec>
<st>
 The <it>n</it>−6 to <it>n</it>−3 ratio </st>

<p>

<indent level="1">

<it>Main article: <link xlink:type="simple" xlink:href="../714/4576714.xml">
Essential fatty acid interactions</link></it>
</indent>
Clinical studies<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%221%22])">1</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2288%22])">88</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2289%22])">89</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2290%22])">90</ref> indicate that the ingested ratio of <it>n</it>−6 to <it>n</it>−3 (especially Linoleic vs Alpha Linolenic) fatty acids is important to maintaining cardiovascular health.
However, two studies<weblink xlink:type="simple" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/17876199?dopt=Citation">
http://www.ncbi.nlm.nih.gov/pubmed/17876199?dopt=Citation</weblink><weblink xlink:type="simple" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/15630029?dopt=Citation">
http://www.ncbi.nlm.nih.gov/pubmed/15630029?dopt=Citation</weblink>, published in 2005 and 2007, found no such correlations in humans.</p>
<p>

Both <it>n</it>−3 and <it>n</it>−6 fatty acids are essential, i.e. humans must consume them in the diet. <it>n</it>−3 and <it>n</it>−6 compete for the same metabolic enzymes, thus the <it>n</it>−6:<it>n</it>−3 ratio will significantly influence the ratio of the ensuing eicosanoids (hormones), (e.g. <link xlink:type="simple" xlink:href="../336/92336.xml">
prostaglandins</link>, <link xlink:type="simple" xlink:href="../155/825155.xml">
leukotrienes</link>, <link xlink:type="simple" xlink:href="../732/900732.xml">
thromboxanes</link> etc.), and will alter the body's metabolic function.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2291%22])">91</ref>  Generally, grass-fed animals accumulate more <it>n</it>−3 than do grain-fed animals which accumulate relatively more <it>n</it>−6. <link xlink:type="simple" xlink:href="../211/1029211.xml">
Metabolites</link> of <it>n</it>−6 are significantly more inflammatory (esp. <link xlink:type="simple" xlink:href="../909/267909.xml">
arachidonic acid</link>) than those of <it>n</it>−3. This necessitates that <it>n</it>−3 and <it>n</it>−6 be consumed in a <it>balanced proportion</it>; healthy ratios of <it>n</it>−6:<it>n</it>−3 range from 1:1 to 4:1.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2292%22])">92</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2293%22])">93</ref> Studies suggest that the evolutionary human diet, rich in game animals, seafood and other sources of <it>n</it>−3, may have provided such a ratio.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2288%22])">88</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2294%22])">94</ref></p>
<p>

Typical Western diets provide ratios of between 10:1 and 30:1 - i.e., dramatically skewed toward <it>n</it>−6.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2295%22])">95</ref> Here are the ratios of <it>n</it>−6 to <it>n</it>−3 fatty acids in some common oils: <link xlink:type="simple" xlink:href="../190/86190.xml">
canola</link> 2:1, <link xlink:type="simple" xlink:href="../784/62784.xml">
soybean</link> 7:1, <link xlink:type="simple" xlink:href="../479/22479.xml">
olive</link> 3–13:1, <link xlink:type="simple" xlink:href="../622/57622.xml">
sunflower</link> (no <it>n</it>−3), <link xlink:type="simple" xlink:href="../869/38869.xml">
flax</link> 1:3,<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2296%22])">96</ref> <link xlink:type="simple" xlink:href="../806/36806.xml">
cottonseed</link> (almost no <it>n</it>−3), <link xlink:type="simple" xlink:href="../602/55602.xml">
peanut</link> (no <it>n</it>−3), <link xlink:type="simple" xlink:href="../249/413249.xml">
grapeseed oil</link> (almost no <it>n</it>−3) and <link xlink:type="simple" xlink:href="../452/2249452.xml">
corn oil</link> 46 to 1 ratio of <it>n</it>−6 to <it>n</it>−3.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2297%22])">97</ref> It should be noted that olive, peanut and canola oils consist of approximately 80% <link xlink:type="simple" xlink:href="../404/1051404.xml">
monounsaturated fatty acid</link>s, (i.e. neither <it>n</it>−6 nor <it>n</it>−3) meaning that they contain relatively small amounts of <it>n</it>−3 and <it>n</it>−6 fatty acids. Consequently, the <it>n</it>−6 to <it>n</it>−3 ratios for these oils (i.e. olive, canola and peanut oils) are not as significant as they are for corn, soybean and sunflower oils.</p>

</sec>
<sec>
<st>
 Conversion efficiency of ALA to EPA and DHA </st>
<p>

It has been reported that conversion of ALA to EPA and further to DHA in humans is limited, but varies with individuals.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2298%22])">98</ref> Women have higher ALA conversion efficiency than men, probably due to the lower rate of utilization of dietary ALA for beta-oxidation. This suggests that biological engineering of ALA conversion efficiency is possible. In the online book of <it>The Benefits of Omega 3 Fatty Acids found in Seal Oil, as Opposed to Fish and Flaxseed Oils</it>, Dr. Ho listed the several factors that inhibit the ALA conversion,<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2299%22])">99</ref> which again indicate that the efficiency of ALA conversion could be adjusted by altering one's dietary habits, such as rebalancing the ratio of <it>n</it>−3 and <it>n</it>−6 fatty acid intake,<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2298%22])">98</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%22100%22])">100</ref> restraining direct alcohol consumptions, and supplementing vitamins and minerals. However, Goyens <it>et al.</it> argues that it is the absolute amount of ALA, rather than the ratio of <it>n</it>−3 and <it>n</it>−6 fatty acids, which affects the conversion.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%22101%22])">101</ref></p>

</sec>
<sec>
<st>
 See also </st>

<p>

<list>
<entry level="1" type="bullet">

 <link>
List of <it>n</it>−3 fatty acids</link></entry>
<entry level="1" type="bullet">

 <link xlink:type="simple" xlink:href="../218/681218.xml">
<it>n</it>−6 fatty acid</link></entry>
<entry level="1" type="bullet">

 <link xlink:type="simple" xlink:href="../439/3110439.xml">
<it>n</it>−9 fatty acid</link></entry>
<entry level="1" type="bullet">

 <link xlink:type="simple" xlink:href="../948/105948.xml">
Essential fatty acid</link></entry>
<entry level="1" type="bullet">

 <link xlink:type="simple" xlink:href="../714/4576714.xml">
Essential fatty acid interactions</link></entry>
<entry level="1" type="bullet">

 <link xlink:type="simple" xlink:href="../249/413249.xml">
Grape seed oil</link></entry>
<entry level="1" type="bullet">

 <group_action wordnetid="101080366" confidence="0.8">
<commercial_enterprise wordnetid="101094725" confidence="0.8">
<transaction wordnetid="101106808" confidence="0.8">
<event wordnetid="100029378" confidence="0.8">
<output wordnetid="100914632" confidence="0.8">
<industry wordnetid="100923444" confidence="0.8">
<act wordnetid="100030358" confidence="0.8">
<psychological_feature wordnetid="100023100" confidence="0.8">
<production wordnetid="100913705" confidence="0.8">
<crop wordnetid="113085864" confidence="0.8">
<commerce wordnetid="101090446" confidence="0.8">
<link xlink:type="simple" xlink:href="../683/1910683.xml">
Camelina sativa</link></commerce>
</crop>
</production>
</psychological_feature>
</act>
</industry>
</output>
</event>
</transaction>
</commercial_enterprise>
</group_action>
</entry>
<entry level="1" type="bullet">

 <link xlink:type="simple" xlink:href="../514/212514.xml">
Cod liver oil</link></entry>
<entry level="1" type="bullet">

 <link xlink:type="simple" xlink:href="../306/999306.xml">
Fish oil</link></entry>
<entry level="1" type="bullet">

 <link xlink:type="simple" xlink:href="../869/38869.xml">
Flax</link></entry>
<entry level="1" type="bullet">

 <link xlink:type="simple" xlink:href="../711/295711.xml">
Linseed oil</link></entry>
<entry level="1" type="bullet">

 <link xlink:type="simple" xlink:href="../860/3399860.xml">
Chia</link></entry>
<entry level="1" type="bullet">

 <plant wordnetid="100017222" confidence="0.8">
<solid wordnetid="115046900" confidence="0.8">
<vascular_plant wordnetid="113083586" confidence="0.8">
<food wordnetid="107555863" confidence="0.8">
<weed wordnetid="113085113" confidence="0.8">
<vegetable wordnetid="107707451" confidence="0.8">
<produce wordnetid="107705711" confidence="0.8">
<link xlink:type="simple" xlink:href="../740/862740.xml">
Purslane</link></produce>
</vegetable>
</weed>
</food>
</vascular_plant>
</solid>
</plant>
</entry>
<entry level="1" type="bullet">

 <link xlink:type="simple" xlink:href="../851/1900851.xml">
Resolvins</link></entry>
<entry level="1" type="bullet">

 <solid wordnetid="115046900" confidence="0.8">
<component wordnetid="103081021" confidence="0.8">
<food wordnetid="107555863" confidence="0.8">
<ingredient wordnetid="103570709" confidence="0.8">
<vegetable wordnetid="107707451" confidence="0.8">
<part wordnetid="103892891" confidence="0.8">
<produce wordnetid="107705711" confidence="0.8">
<link xlink:type="simple" xlink:href="../286/1041286.xml">
Wakame</link></produce>
</part>
</vegetable>
</ingredient>
</food>
</component>
</solid>
</entry>
</list>
</p>


</sec>
<sec>
<st>
Notes and references</st>

<p>

<reflist>
<entry id="1">
 <cite style="font-style:normal"><person wordnetid="100007846" confidence="0.9638700866880419">
<link xlink:type="simple" xlink:href="../903/13167903.xml">
Lands, William E.M.</link></person>
&#32;(May 1992).&#32;"<weblink xlink:type="simple" xlink:href="http://www.fasebj.org/cgi/reprint/6/8/2530/">
Biochemistry and physiology of n–3 fatty acids</weblink>". <it><link xlink:type="simple" xlink:href="../231/16788231.xml">
FASEB Journal</link></it>&#32;<b>6</b>&#32;(8): 2530–2536.&#32;<link xlink:type="simple" xlink:href="../231/16788231.xml">
Federation of American Societies for Experimental Biology</link>. PMID 1592205. Retrieved on <link>
2008-03-21</link>.</cite>&nbsp;</entry>
<entry id="2">
<link xlink:type="simple" xlink:href="../632/11632.xml">
United States Food and Drug Administration</link>&#32;(<link xlink:type="simple" xlink:href="../488/28488.xml">
September 8</link>, <link xlink:type="simple" xlink:href="../524/35524.xml">
2004</link>).&#32;"<weblink xlink:type="simple" xlink:href="http://www.fda.gov/bbs/topics/news/2004/NEW01115.html">
FDA announces qualified health claims for omega-3 fatty acids</weblink>". <link xlink:type="simple" xlink:href="../097/304097.xml">
Press release</link>. &#32;Retrieved on <link>
2006-07-10</link>.</entry>
<entry id="3">
 <cite style="font-style:normal">Morris, Martha C.; Sacks, Frank; Rosner, Bernard&#32;(August 1993).&#32;"<weblink xlink:type="simple" xlink:href="http://circ.ahajournals.org/cgi/reprint/88/2/523/">
Does fish oil lower blood pressure? A meta-analysis of controlled trials</weblink>". <it><work wordnetid="104599396" confidence="0.8">
<product wordnetid="104007894" confidence="0.8">
<creation wordnetid="103129123" confidence="0.8">
<artifact wordnetid="100021939" confidence="0.8">
<periodical wordnetid="106593296" confidence="0.8">
<publication wordnetid="106589574" confidence="0.8">
<link xlink:type="simple" xlink:href="../588/3884588.xml">
Circulation</link></publication>
</periodical>
</artifact>
</creation>
</product>
</work>
</it>&#32;<b>88</b>&#32;(2): 523–533.&#32;<link xlink:type="simple" xlink:href="../673/581673.xml">
American Heart Association</link>. PMID 8339414.</cite>&nbsp;</entry>
<entry id="4">
 <cite style="font-style:normal">Mori, Trevor A.; Bao, Danny Q.; Burke, Valerie; Puddey, Ian B.; Beilin, Lawrence J.&#32;(August 1993).&#32;"<weblink xlink:type="simple" xlink:href="http://hyper.ahajournals.org/cgi/reprint/34/2/253/">
Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans</weblink>". <it>Hypertension</it>&#32;<b>34</b>&#32;(2): 253–260.&#32;<link xlink:type="simple" xlink:href="../673/581673.xml">
American Heart Association</link>. PMID 10454450.</cite>&nbsp;</entry>
<entry id="5">
 <cite style="font-style:normal">Harris, William S.&#32;(May 1997).&#32;"<weblink xlink:type="simple" xlink:href="http://www.ajcn.org/cgi/reprint/65/5/1645S/">
n−3 fatty acids and serum lipoproteins: human studies</weblink>". <it>American Journal of Clinical Nutrition</it>&#32;<b>65</b>&#32;(5 Supplement): 1645S–1654S.&#32;The American Society for Nutrition. PMID 9129504.</cite>&nbsp;</entry>
<entry id="6">
 <cite style="font-style:normal">Sanders, T.A.B.; Oakley, F.R.; Miller, G.J.; Mitropoulos, K.A.; Crook, D.; Oliver, M.F.&#32;(December 1997).&#32;"<weblink xlink:type="simple" xlink:href="http://atvb.ahajournals.org/cgi/content/full/17/12/3449">
Influence of n−6 versus n−3 polyunsaturated fatty acids in diets low in saturated fatty acids on plasma lipoproteins and hemostatic factors</weblink>". <it>Arteriosclerosis, Thrombosis, and Vascular Biology</it>&#32;<b>17</b>&#32;(12): 3449–3460.&#32;<link xlink:type="simple" xlink:href="../673/581673.xml">
American Heart Association</link>. PMID 9437192.</cite>&nbsp;</entry>
<entry id="7">
 <cite style="font-style:normal">Roche, H.M.; Gibney, M.J.&#32;(September 1996).&#32;"<weblink xlink:type="simple" xlink:href="http://cat.inist.fr/?aModele=afficheN&amp;cpsidt=3232572">
Postprandial triacylglycerolaemia: the effect of low-fat dietary treatment with and without fish oil supplementation</weblink>". <it>European Journal of Clinical Nutrition</it>&#32;<b>50</b>&#32;(9): 617–624.&#32;<company wordnetid="108058098" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../095/2212095.xml">
Nature Publishing Group</link></company>
. PMID 8880041.</cite>&nbsp;</entry>
<entry id="8">
 <cite style="font-style:normal">Davidson, Michael H.; Stein, Evan A.; Bays, Harold E.; Maki, Kevin C.; Doyle, Ralph T.; Shalwitz, Robert A.; Ballantyne, Christie M.; Ginsberg, Henry N.&#32;(July 2007).&#32;"Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to Simvastatin 40&nbsp;mg/d in hypertriglyceridemic patients: An 8-week, randomized, double-blind, placebo-controlled study". <it>Clinical Therapeutics</it>&#32;<b>29</b>&#32;(7): 1354–1367.&#32;<company wordnetid="108058098" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../561/420561.xml">
Elsevier</link></company>
. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1016%2Fj.clinthera.2007.07.018">
10.1016/j.clinthera.2007.07.018</weblink>. PMID 17825687.</cite>&nbsp;</entry>
<entry id="9">
 <cite style="font-style:normal">Bucher, Heiner C.; Hengstler, Peter; Schindler, Christian; Meier, Gabriela&#32;(2002).&#32;"n−3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials". <it>The American Journal of Medicine</it>&#32;<b>112</b>&#32;(4): 298–304.&#32;<company wordnetid="108058098" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../561/420561.xml">
Elsevier</link></company>
. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1016%2FS0002-9343%2801%2901114-7">
10.1016/S0002-9343(01)01114-7</weblink>. PMID 11893369.</cite>&nbsp;</entry>
<entry id="10">
 <cite style="font-style:normal">Burr, Michael L.; Sweetham, P.M.; Fehily, Ann M.&#32;(August 1994).&#32;"<weblink xlink:type="simple" xlink:href="http://eurheartj.oxfordjournals.org/cgi/reprint/15/8/1152">
Diet and reinfarction</weblink>". <it>European Heart Journal</it>&#32;<b>15</b>&#32;(8): 1152–1153.&#32;<company wordnetid="108058098" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../518/48518.xml">
Oxford University Press</link></company>
. PMID 7988613.</cite>&nbsp;</entry>
<entry id="11">
 <cite style="font-style:normal">Willett, Walter C.; Stampfer, M.J.; Colditz, G.A.; Speizer, F.E.; Rosner, B.A.; Hennekens, C.H.&#32;(March 1993).&#32;"Intake of trans fatty acids and risk of coronary heart disease among women". <it><periodical wordnetid="106593296" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../899/463899.xml">
The Lancet</link></periodical>
</it>&#32;<b>341</b>&#32;(8845): 581–585.&#32;<company wordnetid="108058098" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../561/420561.xml">
Elsevier</link></company>
. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1016%2F0140-6736%2893%2990350-P">
10.1016/0140-6736(93)90350-P</weblink>. PMID 8094827.</cite>&nbsp;</entry>
<entry id="12">
 <cite style="font-style:normal">Stone, Neil J.&#32;(November 1996).&#32;"<weblink xlink:type="simple" xlink:href="http://circ.ahajournals.org/cgi/content/full/94/9/2337">
Fish consumption, fish oil, lipids, and coronary heart disease</weblink>". <it><work wordnetid="104599396" confidence="0.8">
<product wordnetid="104007894" confidence="0.8">
<creation wordnetid="103129123" confidence="0.8">
<artifact wordnetid="100021939" confidence="0.8">
<periodical wordnetid="106593296" confidence="0.8">
<publication wordnetid="106589574" confidence="0.8">
<link xlink:type="simple" xlink:href="../588/3884588.xml">
Circulation</link></publication>
</periodical>
</artifact>
</creation>
</product>
</work>
</it>&#32;<b>94</b>: 2337–2340.&#32;<link xlink:type="simple" xlink:href="../673/581673.xml">
American Heart Association</link>. PMID 8901708.</cite>&nbsp;</entry>
<entry id="13">
 <cite style="font-style:normal">Fortin, Paul R.; Lew, Robert A.; Liang, Matthew H.; Wright, Elizabeth A.; Beckett, Laurel A.; Chalmers, Thomas C.; Sperling, Richard I.&#32;(November 1995).&#32;"Validation of a meta-analysis: The effects of fish oil in rheumatoid arthritis". <it>Journal of Clinical Epidemiology</it>&#32;<b>48</b>&#32;(11): 1379–1390.&#32;<company wordnetid="108058098" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../561/420561.xml">
Elsevier</link></company>
. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1016%2F0895-4356%2895%2900028-3">
10.1016/0895-4356(95)00028-3</weblink>. PMID 7490601.</cite>&nbsp;</entry>
<entry id="14">
 <cite style="font-style:normal">Kremer, Joel M.; Bigauoette, J.; Michalek, A.V.; Timchalk, M.A.; Lininger, L.; Rynes, R.I.; Huyck, C.; Zieminski, J.; Bartholomew, L.E.&#32;(January 1985).&#32;"<weblink xlink:type="simple" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/2857265">
Effects of manipulation of dietary fatty acids on clinical manifestations of rheumatoid arthritis.</weblink>". <it><periodical wordnetid="106593296" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../899/463899.xml">
The Lancet</link></periodical>
</it>&#32;<b>1</b>&#32;(8422): 184–187.&#32;<company wordnetid="108058098" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../561/420561.xml">
Elsevier</link></company>
. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1016%2FS0140-6736%2885%2992024-0">
10.1016/S0140-6736(85)92024-0</weblink>. PMID 2857265.</cite>&nbsp;</entry>
<entry id="15">
 <cite style="font-style:normal">Christensen, Jeppe H.; Gustenhoff, Peter; Ejlersen, Ejler; Jessen, Torben; Korup, Eva; Rasmussen, Klaus; Dyerberg, Jørn; Schmidt, Erik B.&#32;(January 1995).&#32;"n−3 fatty acids and ventricular extrasystoles in patients with ventricular tachyarrhythmias". <it>Nutrition Research</it>&#32;<b>15</b>&#32;(1): 1–8.&#32;<company wordnetid="108058098" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../561/420561.xml">
Elsevier</link></company>
. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1016%2F0271-5317%2895%2991647-U">
10.1016/0271-5317(95)91647-U</weblink>.</cite>&nbsp;</entry>
<entry id="17">
 <cite style="font-style:normal">Pignier, C.; Revenaz, C.; Rauly-Lestienne, I.; Cussac, D.; Delhon, A.; Gardette, J.; Le Grand, B.&#32;(November 2007).&#32;"<weblink xlink:type="simple" xlink:href="http://www.springerlink.com/content/u454873774830225/">
Direct protective effects of poly-unsaturated fatty acids, DHA and EPA, against activation of cardiac late sodium current</weblink>". <it>Basic Research in Cardiology</it>&#32;<b>102</b>&#32;(6): 553–564.&#32;Steinkopff Verlag. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1007%2Fs00395-007-0676-x">
10.1007/s00395-007-0676-x</weblink>. PMID 17891522.</cite>&nbsp;</entry>
<entry id="16">
 <cite style="font-style:normal">Christensen, Jeppe H.; Gustenhoff, Peter; Korup, Eva; Aarøe, Jens; Toft, Egon; Møller, Torn; Rasmussen, Klaus; Dyerberg, Jørn; Schmidt, Erik B.&#32;(1996-03-16).&#32;"<weblink xlink:type="simple" xlink:href="http://www.bmj.com/cgi/content/full/312/7032/677">
Effect of fish oil on heart rate variability in survivors of myocardial infarction: a double blind randomised controlled trial.</weblink>". <it><periodical wordnetid="106593296" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../927/541927.xml">
British Medical Journal</link></periodical>
</it>&#32;<b>312</b>&#32;(7032): 677–678.&#32;<body wordnetid="107965085" confidence="0.8">
<social_group wordnetid="107950920" confidence="0.8">
<association wordnetid="108049401" confidence="0.8">
<group wordnetid="100031264" confidence="0.8">
<administration wordnetid="108164585" confidence="0.8">
<link xlink:type="simple" xlink:href="../754/911754.xml">
British Medical Association</link></administration>
</group>
</association>
</social_group>
</body>
. PMID 8597736.</cite>&nbsp;</entry>
<entry id="19">
 <cite style="font-style:normal">Naliwaiko, K.; Araújo, R.L.; da Fonseca, R.V.; Castilho, J.C.; Andreatini, R.; Bellissimo, M.I.; Oliveira, B.H.; Martins, E.F.; Curi, R.; Fernandes, L.C.; Ferraz, A.C.&#32;(April 2004).&#32;"<weblink xlink:type="simple" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/15279495">
Effects of fish oil on the central nervous system: a new potential antidepressant?</weblink>". <it>Nutritional Neuroscience</it>&#32;<b>7</b>&#32;(2): 91–99.&#32;<link xlink:type="simple" xlink:href="../290/4413290.xml">
Maney</link>. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1080%2F10284150410001704525">
10.1080/10284150410001704525</weblink>. PMID 15279495.</cite>&nbsp;</entry>
<entry id="18">
 <cite style="font-style:normal">Su, Kuan-Pin; Huang, Shih-Yi; Chiub, Chih-Chiang; Shenc, Winston W.&#32;(August 2003).&#32;"Omega-3 fatty acids in major depressive disorder: A preliminary double-blind, placebo-controlled trial". <it>European Neuropsychopharmacology</it>&#32;<b>13</b>&#32;(4): 267–271.&#32;Elsevier. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1016%2FS0924-977X%2803%2900032-4">
10.1016/S0924-977X(03)00032-4</weblink>. PMID 12888186.</cite>&nbsp;</entry>
<entry id="21">
 <cite style="font-style:normal">Yehuda S., Rabinovitz S., Mostofsky D.I.&#32;(August 2005).&#32;"Mixture of essential fatty acids lowers test anxiety". <it>Nutritional Neuroscience</it>&#32;<b>8</b>&#32;(4): 265–267.&#32;<link xlink:type="simple" xlink:href="../290/4413290.xml">
Maney</link>. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1080%2F10284150500445795">
10.1080/10284150500445795</weblink>. PMID 16491653.</cite>&nbsp;</entry>
<entry id="20">
 <cite style="font-style:normal">Green, Pnina; Hermesh, Haggai; Monselisec, Assaf; Maromb, Sofi; Presburgerb, Gadi; Weizman, Abraham&#32;(February 2006).&#32;"Red cell membrane omega-3 fatty acids are decreased in nondepressed patients with social anxiety disorder". <it>European Neuropsychopharmacology</it>&#32;<b>16</b>&#32;(2): 107–113. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1016%2Fj.euroneuro.2005.07.005">
10.1016/j.euroneuro.2005.07.005</weblink>. PMID 16243493.</cite>&nbsp;</entry>
<entry id="23">
 <cite style="font-style:normal">Keli, S.O.; Feskens, E.J.; Kromhout, D.&#32;(February 1994).&#32;"Fish consumption and risk of stroke: The Zutphen Study". <it>Stroke</it>&#32;<b>25</b>&#32;(2): 328–332. PMID 8303739.</cite>&nbsp;</entry>
<entry id="22">
 <cite style="font-style:normal">Nemets, Boris; Stahl, Ziva; Belmaker, R.H.&#32;(March 2002).&#32;"Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder". <it>American Journal of Psychiatry</it>&#32;<b>159</b>&#32;(3): 477–479.&#32;<social_group wordnetid="107950920" confidence="0.8">
<society wordnetid="107966140" confidence="0.8">
<group wordnetid="100031264" confidence="0.8">
<link xlink:type="simple" xlink:href="../911/160911.xml">
American Psychiatric Association</link></group>
</society>
</social_group>
. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1176%2Fappi.ajp.159.3.477">
10.1176/appi.ajp.159.3.477</weblink>. PMID 11870016.</cite>&nbsp;</entry>
<entry id="25">
 <cite style="font-style:normal">Iso, H.; Rexrode, K.M.; Stampfer, M.J.; Manson, J.E.; Colditz, G.A.; Speizer, F.E.; Hennekens, C.H.; Willett, W.C.&#32;(January 2001).&#32;"Intake of fish and omega-3 fatty acids and risk of stroke in women". <it>JAMA</it>&#32;<b>285</b>&#32;(3): 304–312. PMID 11176840.</cite>&nbsp;</entry>
<entry id="24">
 <cite style="font-style:normal">Gillum, R.F.; Mussolino, M.E.; Madans, J.H.&#32;(March 1996).&#32;"The relationship between fish consumption and stroke incidence: The NHANES I Epidemiologic Follow-up Study (National Health and Nutrition Examination Survey)". <it>Archives of Internal Medicine</it>&#32;<b>156</b>&#32;(5): 537–542. PMID 8604960.</cite>&nbsp;</entry>
<entry id="27">
 <cite style="font-style:normal">Augustsson, Katarina; Michaud, Dominique S.; Rimm, Eric B.; Leitzmann, Michael F.; Stampfer, Meir J.; Willett, Walter C.; Giovannucci, Edward&#32;(January 2003).&#32;"A prospective study of intake of fish and marine fatty acids and prostate cancer". <it>Cancer Epidemiology, Biomarkers &amp; Prevention</it>&#32;<b>12</b>&#32;(1): 64–67. PMID 12540506.</cite>&nbsp;</entry>
<entry id="26">
The U.S. Food and Drug Administration classification - GRAS (Generally Recognized as Safe)</entry>
<entry id="29">
 <cite style="font-style:normal">Caygill, C.P.; Hill, M.J.&#32;(August 1995).&#32;"Fish, n−3 fatty acids and human colorectal and breast cancer mortality". <it>European Journal Of Cancer Prevention</it>&#32;<b>4</b>&#32;(4): 329–332. PMID 7549825.</cite>&nbsp;</entry>
<entry id="28">
 <cite style="font-style:normal">De Deckere, E.A.&#32;(July 1999).&#32;"Possible beneficial effect of fish and fish n−3 polyunsaturated fatty acids in breast and colorectal cancer". <it>European Journal of Cancer Prevention</it>&#32;<b>8</b>&#32;(3): 213–221. PMID 10443950.</cite>&nbsp;</entry>
<entry id="31">
 <cite style="font-style:normal">Lee Hooper et al&#32;(April 2006).&#32;"<weblink xlink:type="simple" xlink:href="http://bmj.bmjjournals.com/cgi/reprint_abr/332/7544/752/">
Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review</weblink>". <it>British Medical Journal</it>&#32;<b>332</b>: 752–760. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1136%2Fbmj.38755.366331.2F">
10.1136/bmj.38755.366331.2F</weblink>. PMID 16565093. Retrieved on <link>
2006-07-07</link>.</cite>&nbsp;</entry>
<entry id="30">
 <cite style="font-style:normal">Catherine H. MacLean, MD, PhD et al&#32;(January 2006).&#32;"<weblink xlink:type="simple" xlink:href="http://jama.ama-assn.org/cgi/content/short/295/4/403">
Effects of n−3 Fatty Acids on Cancer Risk</weblink>". <it>Journal of the American Medical Association</it>&#32;<b>295</b>&#32;(4): 403–415. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1001%2Fjama.295.4.403">
10.1001/jama.295.4.403</weblink>. PMID 16434631. Retrieved on <link>
2006-07-07</link>.</cite>&nbsp;</entry>
<entry id="34">
Trivedi, Bijal&#32;(2006-09-23).&#32;"<weblink xlink:type="simple" xlink:href="http://www.newscientist.com/channel/health/mg19125701.300-the-good-the-fad-and-the-unhealthy.html">
The good, the fad, and the unhealthy</weblink>", <it>New Scientist</it>, pp.&nbsp;42–49.&nbsp;</entry>
<entry id="35">
 <cite style="font-style:normal">Wang, Chenchen; Harris, William S.; Chung, Mei; Lichtenstein, Alice H.; Balk, Ethan M.; Kupelnick, Bruce; Jordan, Harmon S.; Lau, Joseph&#32;(July 2006).&#32;"n−3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review". <it>The American Journal of Clinical Nutrition</it>&#32;<b>84</b>&#32;(1): 5–17. PMID 16825676.</cite>&nbsp;</entry>
<entry id="32">
 <cite style="font-style:normal">&#32;"Dietary supplementation with n−3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial."&#32;&#32;(1999). <it>Lancet</it>&#32;<b>354</b>: 447–455. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1016%2FS0140-6736%2899%2907072-5">
10.1016/S0140-6736(99)07072-5</weblink>. PMID 10465168.</cite>&nbsp;</entry>
<entry id="33">
 <cite style="font-style:normal">Marchioli R.&#32;(2002).&#32;"Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the GISSI-Prevenzione.". <it>Circulation</it>&#32;<b>105</b>: 1897–1903. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1161%2F01.CIR.0000014682.14181.F2">
10.1161/01.CIR.0000014682.14181.F2</weblink>. PMID 11997274.</cite>&nbsp;</entry>
<entry id="38">
 <cite style="font-style:normal">Johnson M, Ostlund S, Fransson G, Kadesjö B, Gillberg C.&#32;(2008 Apr 30).&#32;"Omega-3/Omega-6 Fatty Acids for Attention Deficit Hyperactivity Disorder: A Randomized Placebo-Controlled Trial in Children and Adolescents.". <it>J Atten Disord</it>. PMID 18448859.</cite>&nbsp;</entry>
<entry id="39">
 <cite style="font-style:normal">Mita, Tomoya; Watada, Hirotaka; Ogihara, Takeshi; Nomiyama, Takashi; Ogawa, Osamu; Kinoshita, Junichiro; Shimizu, Tomoaki; Hirose, Takahisa; Tanaka, Yasushi; Kawamori, Ryuzo&#32;(March 2007).&#32;"Eicosapentaenoic acid reduces the progression of carotid intima-media thickness in patients with type 2 diabetes". <it>Atherosclerosis</it>&#32;<b>191</b>&#32;(1): 162–167. PMID 16616147.</cite>&nbsp;</entry>
<entry id="36">
 <cite style="font-style:normal">Mozaffarian, Dariush; Rimm, Eric B.&#32;(October 2006).&#32;"Fish intake, contaminants, and human health: evaluating the risks and the benefits". <it>JAMA</it>&#32;<b>296</b>&#32;(15): 1885–1899. PMID 17047219.</cite>&nbsp;</entry>
<entry id="37">
 <cite style="font-style:normal">Richardson, Alexandra J.; Montgomery, Paul&#32;(May 2005).&#32;"The Oxford-Durham study: a randomized, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder". <it>Pediatrics</it>&#32;<b>115</b>&#32;(5): 1360–1366. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1542%2Fpeds.2004%E2%80%932164">
10.1542/peds.2004–2164</weblink>. PMID 15867048.</cite>&nbsp;</entry>
<entry id="42">
 <cite style="font-style:normal">Damsgaard, Camilla T.; Lauritzen, Lotte; Kjær, Tanja M.R.; Holm, Puk M.I.; Fruekilde, Maj-Britt; Michaelsen, Kim F.; Frøkiær, Hanne&#32;(April 2007).&#32;"<weblink xlink:type="simple" xlink:href="http://jn.nutrition.org/cgi/reprint/137/4/1031">
Fish oil supplementation modulates immune function in healthy infants</weblink>". <it>The Journal of Nutrition</it>&#32;<b>137</b>&#32;(4): 1031–1036. PMID 17374672.</cite>&nbsp;</entry>
<entry id="43">
 <cite style="font-style:normal">Green, Kim N.; Martinez-Coria, Hilda; Khashwji, Hasan; Hall, Eileen B.; Yurko-Mauro, Karin A.; Ellis, Lorie; LaFerla, Frank M.&#32;(April 2007).&#32;"Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-β and tau pathology via a mechanism involving presenilin 1 levels". <it>The Journal of Neuroscience</it>&#32;<b>27</b>&#32;(16): 4385–4395. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1523%2FJNEUROSCI.0055-07.2007">
10.1523/JNEUROSCI.0055-07.2007</weblink>. PMID 17442823.</cite>&nbsp;</entry>
<entry id="40">
 <cite style="font-style:normal">McKenney, James M.; Sica, Domenic&#32;(March 2007).&#32;"Prescription omega-3 fatty acids for the treatment of hypertriglyceridemia". <it>American Journal of Health-System Pharmacy</it>&#32;<b>64</b>&#32;(6): 595–605. PMID 17353568.</cite>&nbsp;</entry>
<entry id="41">
 <cite style="font-style:normal">Yokoyama, Mitsuhiro; Origasa, Hideki; Matsuzaki, Masunori; Matsuzawa, Yuji; Saito, Yasushi; Ishikawa, Yuichi; Oikawa, Shinichi; Sasaki, Jun; Hishida, Hitoshi; Itakura, Hiroshige; Kita, Toru; Kitabatake, Akira; Nakaya, Noriaki; Sakata, Toshiie; Shimada, Kazuyuki; Shirato, Kunio&#32;(March 2007).&#32;"Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis". <it>Lancet</it>&#32;<b>369</b>&#32;(9567): 1090–1098. PMID 17398308.</cite>&nbsp;</entry>
<entry id="46">
 <cite style="font-style:normal">Kris-Etherton, P.; Eckel, R.H.; Howard, B.V.; St  Jeor, S.; Bazzarre, T.L.&#32;(April 2001).&#32;"AHA Science Advisory: Lyon Diet Heart Study. Benefits of a Mediterranean-style, National Cholesterol Education Program/American Heart Association Step I dietary pattern on cardiovascular disease". <it>Circulation</it>&#32;<b>103</b>&#32;(13): 1823–1825. PMID 11282918.</cite>&nbsp;</entry>
<entry id="47">
 <cite style="font-style:normal">Lands, William E.M.&#32;(April 2003).&#32;"Diets could prevent many diseases". <it>Lipids</it>&#32;<b>38</b>&#32;(4): 317–321. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1007%2Fs11745-003-1066-0">
10.1007/s11745-003-1066-0</weblink>. PMID 12848276.</cite>&nbsp;</entry>
<entry id="44">
 <cite style="font-style:normal">Sinn, Natalie; Bryan, Janet&#32;(April 2007).&#32;"Effect of supplementation with polyunsaturated fatty acids and micronutrients on learning and behavior problems associated with child ADHD". <it>Journal of Developmental And Behavioral Pediatrics</it>&#32;<b>28</b>&#32;(2): 82–91. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1097%2F01.DBP.0000267558.88457.a5">
10.1097/01.DBP.0000267558.88457.a5</weblink>. PMID 17435458.</cite>&nbsp;</entry>
<entry id="45">
 <cite style="font-style:normal">Lee, Duk-Hee; Lee, In-Kyu; Jin, Soo-Hee; Steffes, Michael; Jacobs, David R.&#32;(March 2007).&#32;"Association between serum concentrations of persistent organic pollutants and insulin resistance among nondiabetic adults: results from the National Health and Nutrition Examination Survey 1999–2002". <it>Diabetes Care</it>&#32;<b>30</b>&#32;(3): 622–628. PMID 17327331.</cite>&nbsp;</entry>
<entry id="51">
 <cite style="font-style:normal">Garrido-Sánchez, L.; García-Fuentes, E.; Rojo-Martínez, G.; Cardona, F.; Soriguer, F.; Tinahones, F.J.&#32;(February 2008).&#32;"Inverse relation between levels of anti-oxidized-LDL antibodies and eicosapentanoic acid (EPA)". <it>The British Journal of Nutrition</it>&#32;<b>22</b>: 1–5. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1017%2FS0007114508921723">
10.1017/S0007114508921723</weblink>. PMID 18252023.</cite>&nbsp;</entry>
<entry id="50">
 <cite style="font-style:normal">Bousquet, M.; Saint-Pierre, M.; Julien, C.; Salem, N.; Cicchetti, F.; Calon, F.&#32;(April 2008).&#32;"Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson's disease". <it>The <link xlink:type="simple" xlink:href="../231/16788231.xml">
Federation of American Societies for Experimental Biology</link> Journal</it>&#32;<b>22</b>&#32;(4): 1213–1225. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1096%2Ffj.07-9677com">
10.1096/fj.07-9677com</weblink>. PMID 18032633.</cite>&nbsp;</entry>
<entry id="49">
 <cite style="font-style:normal">Zambón, D.; Sabaté, J.; Muñoz, S.; Campero, B.; Casals, E.; Merlos, M.; Laguna, J.C.; Ros, E.&#32;(April 2000).&#32;"Substituting <link xlink:type="simple" xlink:href="../140/165140.xml">
walnut</link>s for monounsaturated fat improves the serum lipid profile of hypercholesterolemic men and women: A randomized crossover trial". <it>Annals of Internal Medicine</it>&#32;<b>132</b>&#32;(7): 538–546. PMID 10744590.</cite>&nbsp;</entry>
<entry id="48">
"<weblink xlink:type="simple" xlink:href="http://www.nutritiondata.com/facts-C00001-01c20oc.html">
Nutrition Facts and Analysis for Nuts, Walnuts, English</weblink>".&#32;<it>NutritionData</it>.</entry>
<entry id="55">
  <cite style="font-style:normal">Kromann, N.; Green, A.&#32;(1980).&#32;"Epidemiological studies in the Upernavik district, Greenland. Incidence of some chronic diseases 1950-1974". <it>Acta Medica Scandinavica</it>&#32;<b>208</b>&#32;(5): 401–406. PMID 7457208.</cite>&nbsp; </entry>
<entry id="54">
"<weblink xlink:type="simple" xlink:href="http://www.oilofpisces.com/bloodcoagulation.html">
Fish Oils and Stroke/Blood Coagulation</weblink>".&#32;<it>oilofpisces.com</it>.</entry>
<entry id="53">
 <cite id="CITEREFLewis" style="font-style:normal">Lewis, Christine J.,&#32;<it><weblink xlink:type="simple" xlink:href="http://www.cfsan.fda.gov/~dms/ds-ltr11.html">
Letter Regarding Dietary Supplement Health Claim for Omega-3 Fatty Acids and Coronary Heart Disease</weblink></it>, </cite>&nbsp;</entry>
<entry id="52">
"<weblink xlink:type="simple" xlink:href="http://dermatologytimes.modernmedicine.com/dermatologytimes/Research+Briefs/Omega-3-can-soothe-eczema/ArticleStandard/Article/detail/505982?contextCategoryId=44290">
Omega-3 can soothe eczema</weblink>", <it>Dermatology Times</it>&#32;(2008-03-27).&nbsp;</entry>
<entry id="59">
 <cite style="font-style:normal">Green, Vanessa A.; Pituch, Keenan A.; Itchon, Jonathan; Choi, Aram; O'Reilly, Mark; Sigafoos, Jeff&#32;(January–February 2006).&#32;"Internet survey of treatments used by parents of children with autism". <it>Research in Developmental Disabilities</it>&#32;<b>27</b>&#32;(1): 70–84. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1016%2Fj.ridd.2004.12.002">
10.1016/j.ridd.2004.12.002</weblink>. PMID 15919178.</cite>&nbsp;</entry>
<entry id="58">
 <cite style="font-style:normal">Levy, Susan E.; Hyman, Susan L.&#32;(2005).&#32;"Novel treatments for autistic spectrum disorders". <it>Mental Retardation and Developmental Disabilities Research Reviews</it>&#32;<b>11</b>&#32;(2): 131–142. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1002%2Fmrdd.20062">
10.1002/mrdd.20062</weblink>. PMID 15977319.</cite>&nbsp;</entry>
<entry id="57">
 <cite style="font-style:normal">Gissi-Hf Investigators&#32;(August 2008).&#32;"<weblink xlink:type="simple" xlink:href="http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(08)61239-8">
Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial</weblink>". <it>Lancet</it>. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1016%2FS0140-6736%2808%2961239-8">
10.1016/S0140-6736(08)61239-8</weblink>. PMID 18757090.</cite>&nbsp;</entry>
<entry id="56">
<physical_entity wordnetid="100001930" confidence="0.8">
<person wordnetid="100007846" confidence="0.8">
<medical_practitioner wordnetid="110305802" confidence="0.8">
<intellectual wordnetid="109621545" confidence="0.8">
<alumnus wordnetid="109786338" confidence="0.8">
<causal_agent wordnetid="100007347" confidence="0.8">
<health_professional wordnetid="110165109" confidence="0.8">
<adult wordnetid="109605289" confidence="0.8">
<professional wordnetid="110480253" confidence="0.8">
<scholar wordnetid="110557854" confidence="0.8">
<doctor wordnetid="110020890" confidence="0.8">
<link xlink:type="simple" xlink:href="../106/5065106.xml">
Ornish, Dean</link></doctor>
</scholar>
</professional>
</adult>
</health_professional>
</causal_agent>
</alumnus>
</intellectual>
</medical_practitioner>
</person>
</physical_entity>
&#32;(<link>
2006-05-02</link>).&#32;"<weblink xlink:type="simple" xlink:href="http://www.newsweek.com/id/137192">
The Dark Side of Good Fats</weblink>", <it><magazine wordnetid="106595351" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../169/214169.xml">
Newsweek</link></magazine>
</it>, p.&nbsp;2.&#32;Retrieved on <link>
2008-06-14</link>.&nbsp;</entry>
<entry id="63">
 <cite style="font-style:normal">Odent, Michel; Colson, Suzanne; De Reu, Paul&#32;(<link>
2002-05-25</link>).&#32;"Consumption of seafood and preterm delivery. Encouraging pregnant women to eat fish did not show effect". <it>BMJ (Clinical Research Ed.)</it>&#32;<b>324</b>&#32;(7348): 1279. PMID 12028992.</cite>&nbsp;</entry>
<entry id="62">
 <cite style="font-style:normal">Olsen, Sjúrður Fróði; Secher, Niels Jørgen&#32;(<link>
2002-02-23</link>).&#32;"Low consumption of seafood in early pregnancy as a risk factor for preterm delivery: prospective cohort study". <it>BMJ (Clinical Research Ed.)</it>&#32;<b>324</b>&#32;(7335): 447. PMID 11859044.</cite>&nbsp;</entry>
<entry id="61">
 <cite style="font-style:normal">Amminger, Paul G.; Berger, Gregor E.; Schäfer, Miriam R.; Klier, Claudia; Friedrich, Max H.; Feucht, Martha&#32;(Feb 2007).&#32;"Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study". <it>Biological Psychiatry</it>&#32;<b>61</b>&#32;(4): 551–553. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1016%2Fj.biopsych.2006.05.007">
10.1016/j.biopsych.2006.05.007</weblink>. PMID 16920077.</cite>&nbsp;</entry>
<entry id="60">
 <cite style="font-style:normal">Richardson, Alexandra J.&#32;(April 2006).&#32;"Omega-3 fatty acids in ADHD and related neurodevelopmental disorders". <it>International Review of Psychiatry</it>&#32;<b>18</b>&#32;(2): 155–172. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1080%2F09540260600583031">
10.1080/09540260600583031</weblink>. PMID 16777670.</cite>&nbsp;</entry>
<entry id="68">
 <cite style="font-style:normal">Huan, Mingming; Hamazaki, Kei; Sun, Yueji; Itomura, Miho; Liu, Hongyan; Kang, Wei; Watanabe, Shiro; Terasawa, Katsutoshi; Hamazaki, Tomohito&#32;(Oct 2004).&#32;"<weblink xlink:type="simple" xlink:href="http://www.journals.elsevierhealth.com/periodicals/bps/article/PIIS0006322304007061/abstract">
Suicide attempt and n−3 fatty acid levels in red blood cells: a case control study in China</weblink>". <it>Biological Psychiatry</it>&#32;<b>56</b>&#32;(7): 490–496. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1016%2Fj.biopsych.2004.06.028">
10.1016/j.biopsych.2004.06.028</weblink>. PMID 15450784.</cite>&nbsp;</entry>
<entry id="69">
 <cite style="font-style:normal">Appleton, Katherine M.; Hayward, Robert C.; Gunnell, David; Peters, Tim J.; Rogers, Peter J.; Kessler, David; Ness, Andrew R.&#32;(December 2006).&#32;"<weblink xlink:type="simple" xlink:href="http://www.ajcn.org/cgi/content/abstract/84/6/1308">
Effects of n−3 long-chain polyunsaturated fatty acids on depressed mood: systematic review of published trials</weblink>". <it>The American Journal of Clinical Nutrition</it>&#32;<b>84</b>&#32;(6): 1308–1316. PMID 17158410.</cite>&nbsp;</entry>
<entry id="70">
 <cite style="font-style:normal">Appleton, Katherine M.; Christian, Leonie M.; Hayward, Robert C.; Heatherley, Susan V.; Gunnell, David; Kessler, David; McNaughton, Sarah A.; Peters, Tim J.; Rogers, Peter J.; Ness, Andrew R.&#32;(February 2008).&#32;"<weblink xlink:type="simple" xlink:href="http://journals.cambridge.org/action/displayAbstract?aid=1642264">
No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial</weblink>". <it>British Journal of Nutrition</it>&#32;<b>99</b>&#32;(2): 421-431.</cite>&nbsp;</entry>
<entry id="71">
 <cite style="font-style:normal" class="book"><link xlink:type="simple" xlink:href="../635/37635.xml">
Food and Nutrition Board, Institute of Medicine of the National Academies</link>&#32;(2005). <weblink xlink:type="simple" xlink:href="http://newton.nap.edu/books/0309085373/html/423.html">
Dietary Reference Intakes For Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids</weblink>.&#32;Washington, DC:&#32;The National Academies Press,&#32;423. ISBN 0-309-08537-3.</cite>&nbsp;</entry>
<entry id="64">
 <cite style="font-style:normal">Puri, Basant K.&#32;(April 2006).&#32;"High-resolution magnetic resonance imaging sinc-interpolation-based subvoxel registration and semi-automated quantitative lateral ventricular morphology employing threshold computation and binary image creation in the study of fatty acid interventions in schizophrenia, depression, chronic fatigue syndrome and Huntington's disease". <it>International Review of Psychiatry</it>&#32;<b>18</b>&#32;(2): 149–154. PMID 16777669.</cite>&nbsp;</entry>
<entry id="65">
 <cite style="font-style:normal">Calabrese, J.R.; Rapport, D.J.; Shelton, M.D.&#32;(May 1999).&#32;"Fish oils and bipolar disorder: A promising but untested treatment". <it>Archives of General Psychiatry</it>&#32;<b>56</b>&#32;(5): 413–414; discussion 415–416. PMID 10232295.</cite>&nbsp;</entry>
<entry id="66">
 <cite style="font-style:normal">Stoll, A.L.; Severus, W.E.; Freeman, M.P.; Rueter, S.; Zboyan, H.A.; Diamond, E.; Cress, K.K.; Marangell, L.B.&#32;(May 1999).&#32;"Omega 3 fatty acids in bipolar disorder: A preliminary double-blind, placebo-controlled trial". <it>Archives of General Psychiatry</it>&#32;<b>56</b>&#32;(5): 407–412. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1001%2Farchpsyc.56.5.407">
10.1001/archpsyc.56.5.407</weblink>. PMID 10232294.</cite>&nbsp;</entry>
<entry id="67">
 <cite style="font-style:normal">Nemets, Hanah; Nemets, Boris; Apter, Alan; Bracha, Ziva; Belmaker, R.H.&#32;(June 2006).&#32;"Omega-3 treatment of childhood depression: A controlled, double-blind pilot study". <it>The American Journal of Psychiatry</it>&#32;<b>163</b>&#32;(6): 1098–1100. PMID 16741212.</cite>&nbsp;</entry>
<entry id="76">
 <cite style="font-style:normal">Beckermann, B.; Beneke, M.; Seitz, I.&#32;(June 1990).&#32;"Comparative bioavailability of eicosapentaenoic acid and docasahexaenoic acid from triglycerides, free fatty acids and ethyl esters in volunteers". <it>Arzneimittel-Forschung</it>&#32;<b>40</b>&#32;(6): 700–704. PMID 2144420.</cite>&nbsp;</entry>
<entry id="77">
 <cite style="font-style:normal" class="book">Thomas Bartram&#32;(1998). Bartram's Encyclopedia of Herbal Medicine,&#32;271.</cite>&nbsp;</entry>
<entry id="78">
"<weblink xlink:type="simple" xlink:href="http://www.vegsoc.org/info/omega3.html">
Information Sheet on Omega 3 fats</weblink>".&#32;<it>Vegetarian Society</it>.</entry>
<entry id="79">
"<weblink xlink:type="simple" xlink:href="http://sofa.bfel.de">
Seed Oil Fatty Acids - SOFA Database Retrieval</weblink>".</entry>
<entry id="72">
 <cite style="font-style:normal" class="book"><link xlink:type="simple" xlink:href="../635/37635.xml">
Food and Nutrition Board, Institute of Medicine of the National Academies</link>&#32;(2005). <weblink xlink:type="simple" xlink:href="http://newton.nap.edu/books/0309085373/html/770.html">
Dietary Reference Intakes For Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids</weblink>.&#32;Washington, DC:&#32;The National Academies Press,&#32;770. ISBN 0-309-08537-3.</cite>&nbsp;</entry>
<entry id="73">
"<weblink xlink:type="simple" xlink:href="http://www.consumerlab.com/results/omega3.asp">
Product Review: Omega-3 Fatty Acids (EPA and DHA) from Fish/Marine Oils</weblink>".&#32;  <link xlink:type="simple" xlink:href="../723/11783723.xml">
ConsumerLab.com</link>&#32;(2005-03-15).&#32;Retrieved on <link>
2007-08-14</link>.</entry>
<entry id="74">
"<weblink xlink:type="simple" xlink:href="http://news.bbc.co.uk/1/hi/health/1911312.stm">
Pollutants found in fish oil capsules</weblink>".</entry>
<entry id="75">
 <cite style="font-style:normal">Lawson, L.D.; Hughes, B.G.&#32;(October 1988).&#32;"Absorption of eicosapentaenoic acid and docosahexaenoic acid from fish oil triacylglycerols or fish oil ethyl esters co-ingested with a high-fat meal". <it>Biochemical and Biophysical Research Communications</it>&#32;<b>156</b>&#32;(2): 960–963. PMID 2847723.</cite>&nbsp;</entry>
<entry id="85">
Azcona, J.O., Schang, M.J., Garcia, P.T., Gallinger, C., R. Ayerza (h), and Coates, W. 2008. Omega-3 enriched broiler meat: The influence of dietary alpha-linolenic omega-3 fatty acid sources on growth, performance and meat fatty acid composition. Canadian Journal of Animal Science, Ottawa, Ontario, Canada, 88:257-269.</entry>
<entry id="84">
"<weblink xlink:type="simple" xlink:href="http://www.csuchico.edu/agr/grsfdbef/health-benefits/ben-o3-o6.html">
Omega-3/Omega-6 fatty acid content of Grass Fed Beef</weblink>".</entry>
<entry id="87">
"<weblink xlink:type="simple" xlink:href="http://www.articlesbase.com/supplements-and-vitamins-articles/omega-369-for-weight-management-a-cardiosterol-approach-435636.html">
Omega 3 Omega 6 Omega 9 for weight management. A Cardiosterol approach by Alta Care Laboratoires</weblink>".</entry>
<entry id="86">
"<weblink xlink:type="simple" xlink:href="http://www.vetscite.org/publish/items/001719/">
More Omega 3 in Organic Milk</weblink>".</entry>
<entry id="81">
Wilkinson, Jennifer.&#32;"<weblink xlink:type="simple" xlink:href="http://www.publish.csiro.au/samples/Nut%20Growers%20GuideSample.pdf">
Nut Grower's Guide: The Complete Handbook for Producers and Hobbyists</weblink>"&#32;(PDF).&#32;Retrieved on <link xlink:type="simple" xlink:href="../570/22570.xml">
21 October</link>, <link xlink:type="simple" xlink:href="../165/36165.xml">
2007</link>.</entry>
<entry id="80">
DeFilippis, Andrew P.;&#32;Laurence S. Sperling.&#32;"<weblink xlink:type="simple" xlink:href="http://www.biovita.fi/suomi/pdf/understanding_omega3.pdf">
Understanding omega-3's</weblink>"&#32;(PDF).&#32;Retrieved on <link xlink:type="simple" xlink:href="../570/22570.xml">
21 October</link>, <link xlink:type="simple" xlink:href="../165/36165.xml">
2007</link>.</entry>
<entry id="83">
 <cite style="font-style:normal">Trebunová, A.; Vasko, L.; Svedová, M.; Kasteľ, R.; Tucková, M.; Mach, P.&#32;(July 2007).&#32;"The influence of omega-3 polyunsaturated fatty acids feeding on composition of fatty acids in fatty tissues and eggs of laying hens". <it>Deutsche Tierärztliche Wochenschrift</it>&#32;<b>114</b>&#32;(7): 275–279. PMID 17724936.</cite>&nbsp;</entry>
<entry id="82">
"<weblink xlink:type="simple" xlink:href="http://www.medicalnewstoday.com/medicalnews.php?newsid=51575">
How Omega-6s Usurped Omega-3s In US Diet</weblink>".</entry>
<entry id="93">
Lands, 2005</entry>
<entry id="92">
Tribole, 2007</entry>
<entry id="95">
Hibbeln <it>et al.</it>, 2006</entry>
<entry id="94">
 <cite style="font-style:normal">Simopoulos AP, Leaf A, Salem Jr N.&#32;"Statement on the essentiality of and recommended dietary intakes for n−6 and n−3 fatty acids". PMID 10991764. Prostaglandins, Leukotrienes and Essential Fatty Acids 2000;63:119–121.</cite>&nbsp;</entry>
<entry id="89">
 <cite style="font-style:normal">Okuyama H&#32;(2001).&#32;"High n−6 to n−3 ratio of dietary fatty acids rather than serum cholesterol as a major risk factor for coronary heart disease.". <it>European Journal of Lipid Science and Technology</it>&#32;<b>103</b>: 418. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1002%2F1438-9312%28200106%29103%3A6418%3A%3AAID-EJLT418%3E3.0.CO%3B2-%23">
10.1002/1438-9312(200106)103:6418::AID-EJLT418&amp;gt;3.0.CO;2-#</weblink>. Eur J Lipid Sci Technol. 2001; 103:418–422..</cite>&nbsp;</entry>
<entry id="88">
 <cite style="font-style:normal">Simopoulos, Artemis P.&#32;(September 2003).&#32;"Importance of the ratio of omega-6/omega-3 essential fatty acids: evolutionary aspects". <it>World Review of Nutrition and Dietetics</it>&#32;<b>92</b>&#32;(Omega-6/Omega-3 Essential Fatty Acid Ratio: The Scientific Evidence): 1–174.&#32;Karger. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1159%2F000073788">
10.1159/000073788</weblink>. PMID 14579680. ISBN 3805576404.</cite>&nbsp;</entry>
<entry id="91">
 <cite style="font-style:normal">Tribole, E.F.&#32;(<link>
2006-03-27</link>).&#32;"<weblink xlink:type="simple" xlink:href="http://www.bmj.com/cgi/eletters/332/7544/752#130637">
Excess Omega-6 Fats Thwart Health Benefits from Omega-3 Fats</weblink>". <it><periodical wordnetid="106593296" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../927/541927.xml">
British Medical Journal</link></periodical>
 Rapid Responses to Hooper, et al., 2006</it>. Retrieved on <link>
2008-03-23</link>.</cite>&nbsp;</entry>
<entry id="90">
 <cite style="font-style:normal">Griffin BA&#32;(2008).&#32;"How relevant is the ratio of dietary n−6 to n−3 polyunsaturated fatty acids to cardiovascular disease risk? Evidence from the OPTILIP study". <it>Curr. Opin. Lipidol.</it>&#32;<b>19</b>&#32;(1): 57–62. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:10.1097/MOL.0b013e3282f2e2a8 (inactive <link>
2008-06-25</link>) . PMID 18196988.</cite>&nbsp;</entry>
<entry id="100">
"<weblink xlink:type="simple" xlink:href="http://www.integratedhealth.com/infoabstract/eicosab.html">
Eicosanoids Abstracts</weblink>".&#32;Retrieved on <link xlink:type="simple" xlink:href="../570/22570.xml">
21 October</link>, <link xlink:type="simple" xlink:href="../165/36165.xml">
2007</link>.</entry>
<entry id="101">
 <cite style="font-style:normal">Goyens, Petra LL; et al..&#32;"<weblink xlink:type="simple" xlink:href="http://www.ajcn.org/cgi/content/abstract/84/1/44">
Conversion of alpha-linolenic acid in humans is influenced by the absolute amounts of alpha-linolenic acid and linoleic acid in the diet and not by their ratio</weblink>". PMID 16825680. Retrieved on <link xlink:type="simple" xlink:href="../570/22570.xml">
21 October</link>, <link xlink:type="simple" xlink:href="../165/36165.xml">
2007</link>.</cite>&nbsp;</entry>
<entry id="98">
"<weblink xlink:type="simple" xlink:href="http://dhaomega3.org/index.php?category=overview&amp;title=Conversion-of-ALA-to-DHA">
Conversion Efficiency of ALA to DHA in Humans</weblink>".&#32;Retrieved on <link xlink:type="simple" xlink:href="../570/22570.xml">
21 October</link>, <link xlink:type="simple" xlink:href="../165/36165.xml">
2007</link>.</entry>
<entry id="99">
Ho, Cosmas.&#32;"<weblink xlink:type="simple" xlink:href="http://www.omega3sealoil.com/Chapter4_3c.html">
Comparing Omega 3's from Fish and Flax Seed Oil</weblink>".&#32;Retrieved on <link xlink:type="simple" xlink:href="../570/22570.xml">
21 October</link>, <link xlink:type="simple" xlink:href="../165/36165.xml">
2007</link>.</entry>
<entry id="96">
Erasmus, Udo, Fats and Oils. 1986. Alive books, Vancouver, ISBN 0-920470-16-5 p. 263 (round-number ratio within ranges given.)</entry>
<entry id="97">
"<weblink xlink:type="simple" xlink:href="http://efaeducation.nih.gov/sig/esstable.html">
Essential Fats in Food Oils, NIH page</weblink>".</entry>
</reflist>
</p>

<ss1>
<st>
Additional sources</st>

<p>

<list>
<entry level="1" type="bullet">

 Robson, A. 2006. "<weblink xlink:type="simple" xlink:href="http://www.nature.com/doifinder/10.1038/4441002d">
Shellfish view of omega-3 and sustainable fisheries</weblink>." Nature 444, 1002.</entry>
<entry level="1" type="bullet">

 Robson, A. 2007. "<weblink xlink:type="simple" xlink:href="http://www.cefas.co.uk/publications/shellfishnews/sfn23.pdf">
Preventing the diseases of civilisation: shellfish, the omega-3:6 balance and human health</weblink>." Shellfish News 23, 25–27</entry>
<entry level="1" type="bullet">

 Cunnane SC (2006) "Survival of the fattest: the key to human brain evolution." M S-MEDECINE SCIENCES 22 (6–7): 659–663.</entry>
<entry level="1" type="bullet">

 Bell, J.G., et al. 2004. "Essential fatty acids and phospholipase A2 in autistic spectrum disorders." Prostaglandins Leukot.Essent.Fatty Acids 71(4):201–204.</entry>
<entry level="1" type="bullet">

 Bartram, Thomas, 1998, Bartram's Encyclopedia of Herbal Medicine, p.271.</entry>
<entry level="1" type="bullet">

 Johnson, S.M., and E. Hollander. 2003. "Evidence that eicosapentaenoic acid is effective in treating autism." J Clin Psychiatry 64(7):848–849.</entry>
<entry level="1" type="bullet">

 Ohara, K. "The <it>n</it>−3 polyunsaturated fatty acid/dopamine hypothesis of schizophrenia." Prog Neuropsychopharmacol Biol Psychiatry. 2007 Mar 30;31(2):469–474.</entry>
<entry level="1" type="bullet">

 Richardson, A.J., and M.A. Ross. 2000. "Fatty acid metabolism in neurodevelopmental disorder: a new perspective on associations between attention-deficit/hyperactivity disorder, dyslexia, dyspraxia and the autistic spectrum." Prostaglandins Leukot.Essent.Fatty Acids 63(1–2):1–9.</entry>
<entry level="1" type="bullet">

 Young, G., and J. Conquer. 2005. "Omega-3 fatty acids and neuropsychiatric disorders." Reprod.Nutr.Dev 45(1):1–28.</entry>
<entry level="1" type="bullet">

 Hibbeln JR, Nieminen LR, Blasbalg TL, Riggs JA, Lands WE. Healthy intakes of <it>n</it>−3 and <it>n</it>−6 fatty acids: estimations considering worldwide diversity. Am J Clin Nutr. 2006 Jun;83(6 Suppl):1483S–1493S.</entry>
<entry level="1" type="bullet">

 Scher, J., and Pillinger, M. "15d-PGJ2: The anti-inflammatory prostaglandin?" Clinical Immunology. 2005 Feb; 114(2):100–109</entry>
</list>
</p>


</ss1>
</sec>
<sec>
<st>
Further reading</st>

<p>

<list>
<entry level="1" type="bullet">

 Allport, Susan. <weblink xlink:type="simple" xlink:href="http://worldcat.org/search?q=The+Queen+of+Fats%3A+Why+Omega-3s+Were+Removed+from+the+Western+Diet+and+What+We+Can+Do+to+Replace+Them&amp;qt=mozilla-search''The">
Queen of Fats: Why Omega-3s Were Removed from the Western Diet and What We Can Do to Replace Them''</weblink>. University of California Press, September 2006. ISBN 978-0-520-24282-1.</entry>
<entry level="1" type="bullet">

 Chow, Ching Kuang. <weblink xlink:type="simple" xlink:href="http://worldcat.org/oclc/25508943&amp;referer=brief_results">
<it>Fatty Acids in Foods and Their Health Implications''</it></weblink>. Routledge Publishing. New York, New York. 2001.</entry>
<entry level="1" type="bullet">

Clover, Charles. <weblink xlink:type="simple" xlink:href="http://worldcat.org/oclc/67383509&amp;referer=brief_results">
<it>The End of the Line: How overfishing is changing the world and what we eat''</it></weblink>. Ebury Press, London 2004. ISBN 0-09-189780-7</entry>
<entry level="1" type="bullet">

 Stoll, Andrew L. <weblink xlink:type="simple" xlink:href="http://worldcat.org/search?q=The+Omega-3+Connection&amp;fq=ap%3AAndrew+L+Stoll&amp;qt=facet_ap%3A''The">
Omega-3 Connection''</weblink>. Simon &amp; Schuster 2001. ISBN 0-684-87138-6, ISBN 0-684-87139-4 (paperback).</entry>
<entry level="1" type="bullet">

 <link xlink:type="simple" xlink:href="../619/3364619.xml">
Erasmus, Udo</link>. <weblink xlink:type="simple" xlink:href="http://worldcat.org/search?q=Fats+That+Heal%2C+Fats+That+Kill&amp;qt=mozilla-search">
<it>Fats That Heal, Fats That Kill''</it></weblink>. 3rd ed. Burnaby (BC): Alive Books; 1993.</entry>
<entry level="1" type="bullet">

 Boyd, Hillary &amp; Basant, Puri K. <weblink xlink:type="simple" xlink:href="http://worldcat.org/oclc/59305855''The">
Natural Way to Beat Depression: the groundbreaking discovery of EPA to change your life.''</weblink> London. Hodder and Stoughton. 2004. ISBN 0-340-82497-2</entry>
<entry level="1" type="bullet">

 Tribole, Evelyn. <weblink xlink:type="simple" xlink:href="http://worldcat.org/oclc/77520775&amp;referer=brief_results">
Ultimate Omega-3 Diet</weblink>" New York. McGraw-Hill. 2007 ISBN 13:978-0-07-146986-9</entry>
<entry level="1" type="bullet">

 Lands, William E.M. "Fish, Omega-3 and Human Health" Champaign. AOCS Press. 2005 ISBN 1-893997-81-2</entry>
<entry level="1" type="bullet">

 Smithers, Lois. <weblink xlink:type="simple" xlink:href="http://www.myproductalert.com/inflammation.html">
<it>The Food Industry's Greed''</it></weblink>. How Misleading Labeling of Omega-3 Foods Undermines American Health.</entry>
</list>
</p>


</sec>
<sec>
<st>
External links</st>

<p>

<table style="background:#f9f9f9; font-size:85%; line-height:110%; ">
<row>
<col>
 <image width="32x28px" src="Portal.svg">
</image>
</col>
<col style="padding:0 0.2em;">
 <b><it>
Food&#32;portal</it></b></col>
</row>
</table>
</p>


<p>

<list>
<entry level="1" type="bullet">

 <weblink xlink:type="simple" xlink:href="http://www.americanheart.org/presenter.jhtml?identifier=4632">
American Heart Assoc "Fish &amp; Omega-3 Fatty Acids"</weblink></entry>
<entry level="1" type="bullet">

 <weblink xlink:type="simple" xlink:href="http://www.amdsupport.ca/articles/86/1/Omega-3-Fatty-Acids-and-the-Prevention-of-Macular-Degeneration/Page1.html">
Omega-3 Prevents Macular Degeneration</weblink></entry>
<entry level="1" type="bullet">

 Further topics and latest scientific research: <weblink xlink:type="simple" xlink:href="http://www.dhaomega3.org">
DHA/EPA Omega-3 Institute</weblink></entry>
<entry level="1" type="bullet">

 BBC News report: <weblink xlink:type="simple" xlink:href="http://news.bbc.co.uk/2/hi/health/4325679.stm">
Oily fish helps cut inflammation</weblink>, <link xlink:type="simple" xlink:href="../197/20197.xml">
March 12</link>, <link xlink:type="simple" xlink:href="../984/35984.xml">
2005</link>.</entry>
<entry level="1" type="bullet">

 University of Maryland Medical Center, <weblink xlink:type="simple" xlink:href="http://www.umm.edu/altmed/ConsSupplements/Omega3FattyAcidscs.html">
omega-3 Fatty Acids</weblink></entry>
<entry level="1" type="bullet">

 <weblink xlink:type="simple" xlink:href="http://www.durhamtrial.org/">
Durham Research: Using Fatty Acids for Enhancing Classroom Achievement</weblink> Website for the Durham Schools Trial, trial on the effects of fatty acids with children who were under performing in class. Funded by the Durham City Council and Oxford University. Their <weblink xlink:type="simple" xlink:href="http://pediatrics.aappublications.org/cgi/content/abstract/115/5/1360">
initial results</weblink> (also available on <weblink xlink:type="simple" xlink:href="http://durham.cergis.com/default.aspx?pid=228">
durhamtrial.org</weblink>) were published in May 2005.</entry>
<entry level="1" type="bullet">

 Read criticism of the above mentioned Durham 'trial' by a columnist for the Guardian at <weblink xlink:type="simple" xlink:href="http://www.badscience.net">
badscience.net</weblink> September 2006</entry>
<entry level="1" type="bullet">

 Essential (Omega-3 and Omega-6) Fatty Acids: <weblink xlink:type="simple" xlink:href="http://lpi.oregonstate.edu/infocenter/othernuts/omega3fa/">
The Linus Pauling Institute Micronutrient Information Center</weblink></entry>
<entry level="1" type="bullet">

 Simopoulos, AP <weblink xlink:type="simple" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=12442909&amp;dopt=Abstract">
The importance of the ratio of omega-6/omega-3 essential fatty acids.</weblink></entry>
<entry level="1" type="bullet">

 <weblink xlink:type="simple" xlink:href="http://www.cfsan.fda.gov/~dms/ds-ltr28.html">
Letter Responding to a Request to Reconsider the Qualified Claim for a Dietary Supplement Health Claim for Omega-3 Fatty Acids and Coronary Heart Disease</weblink></entry>
<entry level="1" type="bullet">

 MedlinePlus Herbs and Supplements: <weblink xlink:type="simple" xlink:href="http://www.nlm.nih.gov/medlineplus/druginfo/natural/patient-fishoil.html">
Omega-3 fatty acids, fish oil, alpha-linolenic acid</weblink></entry>
<entry level="1" type="bullet">

 <weblink xlink:type="simple" xlink:href="http://www.telegraph.co.uk/news/main.jhtml;jsessionid=NOC54WM2O44VLQFIQMFCFGGAVCBQYIV0?xml=/news/2007/11/12/ncurves112.xml">
Another reason why men like curves</weblink> <it>(Daily Telegraph)</it> Omega-3 credited with shaping a woman's figure to be more attractive to men.</entry>
</list>
</p>



<p>

<table style=";" class="navbox" cellspacing="0">
<row>
<col style="padding:2px;">
<table style="width:100%;background:transparent;color:inherit;;" class="nowraplinks collapsible autocollapse " cellspacing="0">
<row>
<header colspan="2" style=";" class="navbox-title">
Types of <link xlink:type="simple" xlink:href="../940/17940.xml">
Lipid</link>s</header>
</row>
<row style="height:2px;">

</row>
<row>
<col style=";;" class="navbox-group">
General</col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<link xlink:type="simple" xlink:href="../746/264746.xml">
Saturated fat</link> | <link xlink:type="simple" xlink:href="../748/264748.xml">
Unsaturated fat</link> | <link xlink:type="simple" xlink:href="../404/1051404.xml">
Monounsaturated fat</link> | <link xlink:type="simple" xlink:href="../513/1610513.xml">
Polyunsaturated fat</link></col>
</row>
<row style="height:2px">

</row>
<row>
<col style=";;" class="navbox-group">
Geometry</col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<link xlink:type="simple" xlink:href="../487/263487.xml">
Trans fat</link> | <link xlink:type="simple" xlink:href="../594/22594.xml">
Omega-3 fatty acid</link> | <link xlink:type="simple" xlink:href="../218/681218.xml">
Omega-6 fatty acid</link> | <link xlink:type="simple" xlink:href="../439/3110439.xml">
Omega-9 fatty acid</link></col>
</row>
<row style="height:2px">

</row>
<row>
<col style=";;" class="navbox-group">
<link xlink:type="simple" xlink:href="../505/24505.xml">
Phospholipid</link>s</col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<link xlink:type="simple" xlink:href="../538/4053538.xml">
Phosphatidylserine</link> | <link xlink:type="simple" xlink:href="../493/1228493.xml">
Phosphatidylinositol</link> | <link xlink:type="simple" xlink:href="../918/9431918.xml">
Phosphatidyl ethanolamine</link> | <link xlink:type="simple" xlink:href="../250/1799250.xml">
Cardiolipin</link> | <link xlink:type="simple" xlink:href="../852/3782852.xml">
Dipalmitoylphosphatidylcholine</link></col>
</row>
<row style="height:2px">

</row>
<row>
<col style=";;" class="navbox-group">
<link xlink:type="simple" xlink:href="../312/631312.xml">
Eicosanoid</link>s</col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<link xlink:type="simple" xlink:href="../909/267909.xml">
Arachidonic acid</link> | <link xlink:type="simple" xlink:href="../336/92336.xml">
Prostaglandin</link> | <link xlink:type="simple" xlink:href="../223/899223.xml">
Prostacyclin</link> | <link xlink:type="simple" xlink:href="../732/900732.xml">
Thromboxane</link> | <link xlink:type="simple" xlink:href="../155/825155.xml">
Leukotriene</link></col>
</row>
<row style="height:2px">

</row>
<row>
<col style=";;" class="navbox-group">
<link xlink:type="simple" xlink:href="../975/10975.xml">
Fatty acid</link>s</col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<link xlink:type="simple" xlink:href="../497/1598497.xml">
Lauric acid</link> | <link xlink:type="simple" xlink:href="../488/542488.xml">
Palmitic acid</link> | <link xlink:type="simple" xlink:href="../038/1718038.xml">
Myristic acid</link> | <link xlink:type="simple" xlink:href="../511/338511.xml">
Stearic acid</link> | <link xlink:type="simple" xlink:href="../774/3127774.xml">
Caprylic acid</link></col>
</row>
<row style="height:2px;">

</row>
<row>
<col colspan="2" style=";" class="navbox-abovebelow">
<b>Major families of <link xlink:type="simple" xlink:href="../954/3954.xml">
biochemicals</link></b>
<link xlink:type="simple" xlink:href="../919/19919.xml">
Saccharides</link> | <link xlink:type="simple" xlink:href="../932/5932.xml">
Carbohydrate</link>s | <link xlink:type="simple" xlink:href="../902/518902.xml">
Glycoside</link>s | | <link xlink:type="simple" xlink:href="../207/1207.xml">
Amino acid</link>s | <link xlink:type="simple" xlink:href="../029/24029.xml">
Peptide</link>s | <link xlink:type="simple" xlink:href="../634/23634.xml">
Protein</link>s | <link xlink:type="simple" xlink:href="../912/164912.xml">
Glycoprotein</link>s | | <link xlink:type="simple" xlink:href="../940/17940.xml">
Lipid</link>s | <link xlink:type="simple" xlink:href="../242/214242.xml">
Terpene</link>s | <link xlink:type="simple" xlink:href="../922/141922.xml">
Steroid</link>s | <link xlink:type="simple" xlink:href="../943/294943.xml">
Carotenoid</link>s  <link xlink:type="simple" xlink:href="../ury/24th_century.xml">
Alkaloid</link>s | <link xlink:type="simple" xlink:href="../080/89080.xml">
Nucleobases</link> | <link xlink:type="simple" xlink:href="../496/21496.xml">
Nucleic acids</link> | | <link xlink:type="simple" xlink:href="../048/543048.xml">
Enzyme cofactors</link> | <link xlink:type="simple" xlink:href="../340/292340.xml">
Flavonoid</link>s | <pesticide wordnetid="114980215" confidence="0.8">
<substance wordnetid="100019613" confidence="0.8">
<artifact wordnetid="100021939" confidence="0.8">
<merchandise wordnetid="103748886" confidence="0.8">
<commodity wordnetid="103076708" confidence="0.8">
<chemical wordnetid="114806838" confidence="0.8">
<insecticide wordnetid="114919948" confidence="0.8">
<part wordnetid="113809207" confidence="0.8">
<material wordnetid="114580897" confidence="0.8">
<link xlink:type="simple" xlink:href="../830/1076830.xml">
Polyketide</link></material>
</part>
</insecticide>
</chemical>
</commodity>
</merchandise>
</artifact>
</substance>
</pesticide>
s | <link xlink:type="simple" xlink:href="../547/2258547.xml">
Tetrapyrrole</link>s</col>
</row>
</table>
</col>
</row>
</table>
</p>



</sec>
</bdy>
</therapy>
</article>
